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Individual cells utilize series of biochemical reactions, called signaling pathways, to
translate environmental conditions to physiological responses. Consequently, the
emergent properties of these signaling pathways are constrained to the physico-
chemical laws of their biochemical constituents - they are strongly dependent on
the number of molecular components per cell, intrinsically stochastic (noisy), and
are inherently nonlinear. While these properties provide the plasticity required for
a functioning living system, they present challenges for our understanding and con-
trol of cellular behavior. In this thesis I present single cell measurements (i.e. flow
cytometry data) and physical models that we developed to track fluctuations in
protein and phospho-protein abundance throughout biochemical reaction networks,
and demonstrate how the nonlinear properties of biochemical reactions produce
unique network responses to the targeted chemical inhibition of enzymes. We track
the logarithmic fluctuations of biochemical components using a system of chemi-
cal Langevin equations and the corresponding Lyapunov equation. Used together,
these equations uncover the connection between the organization of signaling path-
way constituents and the covariance matrix estimated from the experimental data.
With this formalism we theoretically explore the unique covariance representations
of various signaling pathways, and experimentally validate our method in two es-
tablished systems: a synthetic E. coli gene regulatory network and the Mitogen
Activated Protein Kinase (MAPK) cascade in primary mouse T lymphocytes. In
addition, we use single cell measurements to mechanistically uncover the unique
responses of signaling pathways, analog or digital, to targeted chemical inhibition.
We extend these short time-scale properties of signaling pathways to a functional
response, proliferation. Lastly, we show how the endogenous diversity of protein
abundance among single cell clones provides a mechanism of resilience to chemical
inhibition. Together, our combined experimental and theoretical approach pro-
vides novel insights to cellular systems, a method for directional inference, and
optimal drug selection.
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CHAPTER 1
INTRODUCTION
Cancer represents a set of heterogeneous diseases that involve the pathological
growth of cells within multicellular organisms. Despite the heterogeneity among
types of cancers, these diseases share a common origin, that is the the accumula-
tion of mutations and co-opted biological resources that manifest into six canonical
behaviors, or ‘hallmarks’: sustained growth signals, evasion of growth suppressors,
bypassing cell death mechanisms, unlimited reproductive capacity, reorganizing
the micro-environment (e.g. angiogenesis), and metastasis [37]. As a result, dis-
ease management requires the selective disruption of these gained attributes in the
pathological cells. While there have been many successful strategies introduced to
treat cancer - general chemotherapies, targeted inhibitors (e.g. Imatinib [43, 44],
Gefitnib [61], and Vemurafenib [18]), as well as immunological agents (e.g. mon-
oclonal antibodies targeting either HER2 [9], Cytotoxic T-lymphocyte-associate
Antigen 4 (CTLA4), and programmed cell death protein 1 (PD-1) [62]) - the com-
plexity of selectively drugging tumors remains staggering.
One such complexity is the intrinsic heterogeneity in biological systems. In-
deed, single cell studies have revealed that clonal cells respond variably to uniform
perturbations [58, 21]. Often times exhibiting unique signal transduction responses
to inhibitors [65, 75, 49, 12], diverse preferences for differentiation and prolifera-
tion [19, 79], and variable susceptibilities to death [7, 76]. Moreover, many of these
phenotypes are not heritable to daughter cells. This lack of memory constrains the
biological processes that can generate these observations. Mechanistic studies of
cell behavior have produced promising progress by attributing the observed diver-
sity to the physico-chemical properties of the cellular constituents [1, 80]. The
1
extent in which biological systems use these laws as a source of diversity and its
application in disease remains to be determined.
1.1 Non-genetic phenotypic individuality, and maintenance
of cellular diversity
Measurements that identified unique responses of individual cell clones to singular
perturbations were pioneered in bacterial studies. An example is the elegant ex-
periments of Balaban et al [7], who demonstrated that individual E. coli respond
uniquely to treatment with Ampicillin. In their experiments they grew E. coli cells
in small microfluidic channels that aligned the bacteria single file. They recorded
the divisions of individual cells exposed to cycles of growth media and lethal doses
Ampicillin. Upon Ampicillin administration a small population of slow growing
cells remained and were designated ‘persister cells’. Indeed, a possible mechanism
of the apparent resilience of these persister cells is the presence of de novo muta-
tions that conferred resistance to the antibiotic. However, this was not the case,
upon reintroduction of Ampicillin the persister cell progeny were equally suscepti-
ble to the drug as the initial population, demonstrating that the persistence state
was not heritable. These results suggest that the bacteria switched stochastically
between a drug tolerant persistence state and a drug sensitive proliferative state.
Indeed, stochastic switching of individual cells between states has been shown
to be an effective mechanism of a population response to changing environments
in systems where individuals do not have the capacity to measure environmental
conditions [50, 1, 10].
In context of human disease, Gupta et al [36] showed similar behavior in human
breast cancer derived cell lines. In theses cell lines, SUM149 and SUM159, the pop-
2
ulation of cells are composed of three cellular states, namely: basal, luminal, and
stem-like. Presumably, each of these cell states represent stable populations, and
that separation of these cells by fluorescence activated cell sorting (FACS) followed
by independent cultures should create populations enriched for the respective phe-
notypes. However, after six days in culture, flow cytometry measurements revealed
that each population reestablished the exact distribution of cell types as originally
found in the parent culture. Indicating that diversity of cell states in cancer is not
exclusively established by cancer stem cells. Moreover, similar findings were found
in other mammalian cells. Mouse embryonic stem cells were found to stochas-
tically maintain the frequency of Stella+Pecam1+ and Stella−Pecam1−, markers
correlative of hypothesized stem cell states, with a time scale of several days [38].
Similarly, mouse epithelial progenitor cells have been found to tune their respective
proliferative versus differentiation bias in accordance with state of the system to
maintain homeostasis [27]. While the utility in stochastic switching is clear, the
actual molecular origins of the stochastic behavior are elusive.
Spudich and Koshland [77] were among the first to experimentally document
and characterize cellular individuality. In their seminal work, they showed that in-
dividual bacteria exhibited unique flagellar response to chemoattractant. A seem-
ingly unsurprising result considering the small abundance of each molecular com-
ponent in the bacterial chemotaxis response pathway. Indeed, signaling pathways
at this small scale are prone to stochasticity introduced from chemical reactions
[34]. However, when they measured the individual responses of the bacteria they
found that the individuality persisted for the lifetime of the bacterium. If indeed
the individuality originated from the intrinsic fluctuations of chemical reactions,
the measured behavior would persist for the lifetime of the chemical reactions,
which is much shorter than the cell lifetime. A crucial fact that the authors used
3
to implicate protein variability as the origin of this non-genetic diversity [26].
A more direct linkage of phenotypic diversity to molecular components was
found in a more complex setting, tumor necrosis factor related apoptosis-inducing
ligand (TRAIL) induced apoptosis of HeLa cells [76]. These experiments consisted
of tracking sister cells from birth to TRAIL induced mitochondria outer-membrane
permeabilization (MOMP), a proxy for apoptosis and cell death, by time lapse
fluorescent microscopy (Figure 1.1A). MOMP was measured by the release of IMS-
RP, a fusion of red fluorescent protein (RFP) to a mitochondrial import sequence
[2], from within the mitochondria to the cytosol. Cells were imaged and tracked
for 20-30 hours prior to the treatment with exogenous TRAIL or TRAIL and
cycloheximide, a potent inhibitor of protein synthesis. Figure 1.1B shows the
correlation of individual sister cells time to MOMP with respect to their average
life time. Immediately after cell division, the resulting two sister cells are effectively
identical and as a result exhibit a high correlation in their times to TRAIL induced
death. However, as the lifetime of the sister cells increases they become more
dissimilar, which results in a small correlation in their death times. In cells treated
with only TRAIL the correlation timescale, a measure of the memory, was only
1.5 hours. However, upon inhibiting the production of protein the correlation
timescale increased to 11 hours (Figure 1.1B). Indeed over-expression of BID, a
protein in the apoptotic regulatory signaling pathway, correlated with individual
cell death times. These results suggest that protein production can function as an
internal stochastic process that ‘mixes’ the time to death of individual cells.
4
other proteins10. To determine the impact of variability in protein
levels on variability in time-to-death, we turned to an ordinary
differential equation model of TRAIL-induced apoptosis12. This
model encapsulates the biochemistry of TRAIL-mediated death
and recapitulates the dynamics of apoptosis under various condi-
tions of protein depletion or overexpression12. When variability in
Td arising fromvariance in protein levels wasmodelled, a goodmatch
was observed to experimental data (Fig. 2b–d) indicating that the
measured differences in protein levels are sufficient to account for
variability in Td.
Next, we investigated which steps in receptor-mediated apoptosis
are responsible for variation in time-to-death. To address this ques-
tion, we grouped reactions into three sets: those occurring before,
during, or subsequent to MOMP (Fig. 3a, blue, grey and orange).
Before MOMP, TRAIL binds and oligomerizes DR4/5 receptors,
promoting assembly of death-inducing signalling complexes
(DISCs) that then activate initiator pro-caspases-8 and -10 (CASP8
and CASP10)19. Active CASP8/10 cleave BID to a truncated form
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Figure 1 | The time-to-death is highly correlated between HeLa sister cells,
but correlation decays as a function of time since division. a, Schematic of
the experimental design. DTd represents the difference in time of MOMP
between sisters; T(Div?MOMP)avg denotes the time between cytokinesis of
the mother and the average time of MOMP in daughter cells; T(Div?Stim)
denotes the time between cytokinesis and TRAIL addition. The shading of
each cell depicts concentrations/states of relevant proteins. b, f, Similarity in
Td among pairs of recently divided sister cells (T(Div?MOMP)avg, 7 h for
b and, 3.5 h for f). c, g, Td as a function of T(Div?Stim), a proxy for cell
cycle state (R2, 0.03). d, h, DTd as a function of T(Div?MOMP)avg.
e, i, Decay in the correlation of Td between sister pairs as a function of
T(Div?MOMP)avg. In i, black circles represent data for cells treated with
TRAIL plus cycloheximide, imaged under the same conditions as the
TRAIL-alone treatment (Supplementary Fig. 5).
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and recapitulates the dynamics of apoptosis under various condi-
tions of protein depletion or overexpression12. When variability in
Td arising fromvariance in protein levels wasmodelled, a goodmatch
was observed to experimental data (Fig. 2b–d) indicating that the
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b and, 3.5 h for f). c, g, Td as a function of T(Div?Stim), a proxy for cell
cycle state (R2, 0.03). d, h, DTd as a function of T(Div?MOMP)avg.
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A B
Figure 1.1: Time to TRAIL induced apoptosis. Reprinted by permission
from Macmillan Publishers Ltd: Nature [76], copyright (2009). (A) Experimental
design testing protein production variability as the mechan sm for diverse death
times of HELA cells treated with TRAIL. (B) Correlation of time to death among
sister cells as a function of the average time between the mother’s division and
their respective time of MOMP.
1.2 Diversity of protein manifest to variable phenotypic
responses
Unique phenotypic responses of individual cells has been correlate with the en-
dogenous variability of protein in many biological settings. For example the vari-
able abundance of the surface receptor Sca-1 n hematopoi tic progenitor cells was
shown to tune the differentiation rate into erythroid or myeloid lineages upon ac-
tivation with Erythropoietin and GM-CSF, respectively [17]. Furthermore, they
found that Sca-1 abundance per cell was stochastically maintained. Mechanisms
to which the relative abundance of Sca-1 bias individual cell’s differentiation rates
are generally unknown. Although, an intuitive explanation is that Sca-1 diver-
sity produces heterogeneous signaling response as implicated by Spencer et al in
TRAIL induced apoptosis. Evidence of such a mechanism can be found in single
cell measurements of AKT and ERK sig aling in at adrenal pheochromocytoma
(PC12) cells. Classic experiments showed that administering epidermal growth
factor (EGF) or neuronal growth factor (NGF) to PC12 cells induced prolif ration
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or differentiation into neurons, respectively [72]. This work was followed by single
cell measurements of phospho-AKT (pAKT) and phospho-ERK (pERK) responses
of PC12 cells to EGF or NGF stimulation. The pAKT and pERK plane identified
a boundary of the phenotypic responses - pAKT signaling biased proliferation and
pERK biased differentiation [19]. In addition, the response of cells to stimulation
was often heterogeneous, the distribution of pAKT and pERK in single cells always
spanned both sides of the boundary. As a result the respective stimulations modu-
lated the fraction of cells exhibiting either phenotype. It remains to be shown if the
abundance of Sca-1 in individual cells correlates with phospho-signaling responses
that ultimately lead to unique phenotypic responses.
Independent measurements in T lymphocytes (T cells) has demonstrated the
connection between protein expression variability and phospho-response diversity.
One such example was found in peptide bound multi-Histocompatibility complex
(pMHC) activation of the MAPK pathway in CD8+ T cells. Single cell measure-
ments simultaneously measuring both ppERK and CD8 demonstrated that the
abundance CD8 correlated with the probability that a cell was activated. More-
over, measurements of the half effective quantity of antigen required for ERK
activation (EC50) revealed an anticorrelation with CD8. Complementing their
measurements, detailed mechanistic models of TCR signaling reproduced the ob-
served dependence of EC50 with CD8 [31]. Similarly, Cotari and Voisinne et al [22]
demonstrated 100 fold change in the sensitivity of STAT5 phosphorylation among
clones responding to Interleukin 2 (IL-2) according to the relative abundance of the
IL2 receptor α chain (IL2Rα) per cell. They followed this observation by showing
how cytokine receptors compete for a common component, namely the common
γ chain. Consequently, the abundance of IL2Rα tuned the responsiveness of cells
signaling through the IL-7 pathway by sequestering the common γ chain from the
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IL7 receptor α chain, and as a result inhibits IL-7 signaling. Interestingly, a sep-
arate study showed that reintroduction of CD8+ T cells sorted by their IL2Rα
expression (low, hi) into an LCMV infected mouse developed different frequencies
of memory and effector cells [41]. It is tempting to attribute this result to the work
of Cotari and Voisinne et al. Indeed, protein variability is an attractive mechanism
to break symmetric responses of individual clones to stimuli.
The composite of all these experimental observations - that protein abundance
is diverse among single cell clones, tunes the responsiveness of signal transduc-
tion pathways and lastly bias cell fate - suggest that the endogenous variability
of protein is an important property of biological systems. However, it is not clear
what mechanisms can biological systems utilize to generate the observed diversity.
Specifically, does the diversity arise from very subtle differences in the cell’s en-
vironment (extrinsic noise in gene expression)? Or, does the variability manifest
from internal processes (intrinsic noise in gene expression), would cells in a ‘per-
fectly’ homogeneous environment exhibit unique phenotypes? Understanding the
mechanisms of protein abundance variability would identify the extent in which
biological systems can rely on these tools to establish diversity.
1.3 The physical origins of gene expression variability
The theoretical tools to study the intrinsic properties of protein abundance fluc-
tuations preceded experimental capabilities by more the twenty five years [84, 34].
As a result, there are numerous results that characterize the magnitude of protein
abundance fluctuations [26, 13], numerical analysis of the propagation of protein
fluctuations through gene regulatory networks [54], and establishment of funda-
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mental limits to which negative regulation can decrease undesired variability [63].
Of particular interest is Thattai and van Oudenaarden’s [82] development of a
simple and analytical framework to study the magnitude of protein fluctuations
for various gene regulatory networks.
In this work Thattai and van Oudenaarden assumed that the fluctuations in
protein abundance are the manifestation of the intrinsically stochastic properties
of the chemical processes comprising the central dogma of molecular biology [23].
Indeed, the canonical mathematical representation of these processes is the Mas-
ter equation, which attributes the time derivative of the probability in observing n
molecules to the sum of the production and degradation of the probabilistic pro-
cesses. In this case, there are three biological species they keep track of: DNA,
RNA, and protein, which results in the Master equation
d
dt
f(~n, t) =
N∑
j=1
{
E+1j λjnjf(~n, t) +
(
E−1j − 1
) N∑
i=1
ajinif(~n, t)
}
−
N∑
i=1
λinif(~n, t), (1.1)
where f(~n, t) represents the joint probability of observing ni copies of the i
th bio-
chemical species for all i = {1, 2, . . . , N} at time t. The operators E±j repre-
sents van Kampen’s [84] translational operator, which takes E±j njf(~n) → (nj ±
1)f(n1, . . . , nj ± 1, . . . nN). Lastly, the constants aji’s represent the response of
species j to species i, ajj = 0 for all j, and λi’s are decay constants. Solving
Equation 1.1 for f(~n, t) is often a difficult task, and is made easier by exploiting
the properties of generating functions.
Generating functions are standard approach for solving Master equations when
the coefficients are linear with respect to the abundance of each variable ni (remem-
ber ni counts molecules, therefore they are integers). The goal of the generating
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function is to recast the problem into a partial differential equation with respect
to new continuous variables zi for each biochemical species and the generating
function F . By switching to this representation one can now utilize the many
toolboxes for solving PDE’s to find the desired probability distribution. However,
there is an alternative benefit of using generating functions. That is, they provide
a method for assessing the moments of the the corresponding stochastic process.
This problem is often far easier than solving for the entire probability distribution.
Thattai and van Oudenaarden [82] used this approach to compute the fluctuations.
First, they computed the expression for the generating function that corresponded
to their stochastic representation of the biology’s central dogma,
∂F
∂t
=
N∑
j=1
(1− zj)
(
λ
∂F
∂zj
−
N∑
i=1
ajizi
∂F
∂zi
)
. (1.2)
To continue, they set the partial derivative with respect to time to zero - they only
cared about the steady state moments. Next, Taylor expanding this expression
with respect to all zi’s about zi’s = 1, provided the moment generating function
of the steady state probability distribution. From this they developed a general
expression for the steady state averages (J) and the covariances (K),
(A−Λ)J = 0, (1.3a)
(A−Λ)K + L = −[(A−Λ)K + L]T , (1.3b)
where Λ is a diagonal N x N matrix of λi’s, A is the matrix connectivity that
describes the interacting biochemical species, J is the N x 1 vector of averages,
K is the N x N covariance matrix, and lastly the elements of L are Lji = ajiJi.
Therefore, by constructing the matrix A and substituting it into Equation 1.3 they
are able to compute the statistics of each biochemical species of the model.
Figure 1.2 represents their model characterizing the statistics of the central
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Figure 1.2: Modeling the central dogma of molecular biology. The model
and corresponding parameters analyzed by Thattai and van Oudenaarden [82]
dogma. The mathematical representation of this process takes the form of,
A =

0 0 0
krna 0 0
0 kprotein 0
 , and Λ =

0 0 0
0 λrna 0
0 0 λprotein
 , (1.4)
which can then be substituted into Equation 1.3 to find the mean and variance of
this process. In this model, the top row represents the dynamics of DNA abun-
dance, which doesn’t change (i.e. no cell cycle), the second row represents the
dynamics of RNA, and lastly the third row represents the dynamics of protein
production. The results are reported as the Fano factor, a quantity that char-
acterizes the variance of the distribution normalized to the mean. This quantity
is ideal for contextualizing properties of the fluctuations in protein abundance -
i.e. identifies sets of kinetic parameters that result in exceedingly variable protein
abundance given the mean expression. As a result, this quantity is important to
consider in biological systems that tune their gene expression parameters to max-
imally or minimally diversify their population. Furthermore, if protein abundance
fluctuations are small and behave according to Poisson statistics the Fano factor
will be unity. The Fano factor for the fluctuations of protein abundance according
to this model is,
σ2protein
µprotein
=
b
1 + γ
+ 1 ≈ b+ 1, (1.5)
where b =
kprotein
λrna
, and γ =
λprotein
λrna
. Burst size, b, represents the number of pro-
teins translated per RNA transcript, and γ quantifies the separation of RNA and
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protein dynamic timescales. Equation 1.5 represents the success of the analysis,
by specifically attributing the fluctuations in protein abundance in physiological
conditions (λprotein  λrna) to the burst size. Moreover, the fluctuations are larger
than those estimated by Poisson statistics, and by tuning the kinetic parameters of
b individual cells can tune the diversity of protein abundance among clones. Fur-
thermore, Equation 1.5 provides the functional dependence of the fluctuations to
the separation of RNA and protein degradation timescales. Indeed, if physiological
conditions were such that λprotein  λrna then, the protein levels would exactly
reflect the RNA abundance. Considering this scenario in Equation 1.5 by setting
γ →∞ we see that the fluctuations converge to the Poisson limit. Taken together,
cells can carefully tune both γ and b to create more or less diverse populations.
Cells can also tune their gene products by constructing feedback regulated cir-
cuits. Indeed, negative feedback regulation is an important mechanism to tune the
probability distribution of protein products [63]. To incorporate this mechanism
into their analytic expression (Eq 1.3), Thattai and van Oudenaarden took
A =

0 0 0
krna 0 −kfeedbackrna
0 kprotein 0
 , (1.6)
while not changing Λ. The corresponding Fano factor is,
σ2protein
µprotein
=
(
1− φ
1 + bφ
)(
b
1 + γ
)
+ 1, (1.7)
where φ = k
feedback
rna
γp
and represents the feedback strength. Indeed, comparing the
Fano factors of the feedback regulated motif (Eq 1.7) to that of the unregulated
protein synthesis model (Eq 1.5) reveals the advantages of feedback. By tuning
the strength of the feedback, φ, cells can precisely tune the fluctuations in protein
abundance to levels below the Poisson limit, a result corroborated by many other
studies [63, 81, 73].
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Extending these results to the observed diversity in biological systems is partic-
ularly intriguing. The ability of cells to tune their protein abundance fluctuations
suggests that in some cases they intentionally diversify by tuning the kinetic pa-
rameters of protein synthesis. In contrast, important regulatory pathways such as
apoptosis need to be tightly controlled, which may explain why over-expression
studies in HeLa cells were required to correlate variability in cells time to death
[76]. Yet, despite the elegance of their solution, and its obvious implications to
the numerous accounts of biological diversity, the relevance of intrinsic fluctuations
had yet to be vetted.
Advances in synthetic biology and fluorescent microscopy provided the tools re-
quired to separate the mechanisms of protein variation among single cells (intrinsic
and extrinsic noise). Elowitz et al [28] decomposed these sources of variability by
making strains of E. coli that encode both cfp and yfp under identical promoters
and integrated symmetrically about the origin of replication. By measuring each
fluorescent protein in individual cells they were able to estimate the contributions
of both sources of diversity. They reported that indeed individual cells exhibited
variation in protein abundance that both correlated (extrinsic) and did not corre-
late (intrinsic) with one another. Moreover, they reported that the square of the
coefficient of variation depreciated with increased promoter activity. In context of
Thattai and van Oudenaarden’s analysis increased promoter activity is represented
by an increase in krna. Computing the corresponding coefficient of variation,
CV2 =
λprotein
krnab
[
b
1 + γ
+ 1
]
, (1.8)
which shows the explicit dependence of the promoter strength in reducing the
measured coefficient of variation. This result published by Elowitz et al. [28]
was the first experimental confirmation that fluctuations of protein in biological
systems can originate from the statistics of cell internal processes.
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Indeed, Elowitz et al. experimentally vetted the fundamental assumption of
Master equation description of protein synthesis. The next important attribute to
consider is the prediction that protein production burst exists and dominate the
variability. Measurements of this process were beautifully conducted with single
E. coli cells in microfluidic chambers (volume ≈ 100 pL, Fig 1.3A) and media sup-
plemented with fluorescein-di-β-D-galactopyranoside (FDG, Fig 1.3C) [16]. FDG
is enzymatically hydrolyzed by β-galactosidase (β-gal), an enzyme produced by
E. coli to digest lactose and other complex sugars, into galactose and the fluo-
rescent molecule fluorescein. Fluorescein in E. coli is quickly pumped out of the
cell, and without the small volume of the microfluidic device would be unmeasur-
able by fluorescence microscopy. Real time fluorescent measurements of fluorescein
abundance revealed that the time derivative of fluorescein accumulation increased
in jumps (Figure 1.3B,D). The magnitude of these jumps are proportional to the
number of β-gal molecules produced per burst of protein synthesis - the net speed
of FDG hydrolysis is proportional to the number of enzymes present. A histogram
of the number of β-gal enzymes produced per burst uncovered an exponential dis-
tribution with on average 5 proteins produced per burst (Figure 1.3E). The shape
of the distribution is reflective of the exponential life-time of mRNA in the cells,
and is in complete agreement with the model assumptions of Thattai and van
Oudenaarden [82].
With these experimental facts established, Friedman et al. [33] extended the
work of Thattai and van Oudenaarden by deriving an analytical distribution of
protein abundance per cell. They found that protein abundance per cell could
be approximated by a continuous and long-tailed Gamma distribution. Indeed,
subsequent analysis confirmed that long-tailed distribution of protein is universal
across all phylogenies [68, 70]. Together, these results show that protein variability
13
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Stochastic protein expression in individual cells at
the single molecule level
Long Cai1*, Nir Friedman1* & X. Sunney Xie1
In a living cell, gene expression—the transcription of DNA to
messenger RNA followed by translation to protein—occurs
stochastically, as a consequence of the low copy number of DNA
and mRNA molecules involved1–6. These stochastic events of
protein production are difficult to observe directly with measure-
ments on large ensembles of cells owing to lack of synchroniza-
tion among cells. Measurements so far on single cells lack the
sensitivity to resolve individual events of protein production.
Here we demonstrate a microfluidic-based assay that allows
real-time observation of the expression of b-galactosidase in
living Escherichia coli cells with single molecule sensitivity. We
observe that protein production occurs in bursts, with the
number of molecules per burst following an exponential distri-
bution. We show that the two key parameters of protein
expression—the burst size and frequency—can be either deter-
mined directly from real-time monitoring of protein production
or extracted from a measurement of the steady-state copy
number distribution in a population of cells. Application of
this assay to probe gene expression in individual budding yeast
and mouse embryonic stem cells demonstrates its generality.
Many important proteins are expressed at low levels7,8, and are
thus inaccessible by current genomic and proteomic techniques.
This microfluidic single cell assay opens up possibilities for
system-wide characterization of the expression of these low
copy number proteins.
b-galactosidase (b-gal) has been the standard reporter for gene
expression in both prokaryotic and eukaryotic cells9–12. Only active as
a tetramer, a single molecule of b-gal can produce a large number of
fluorescent product molecules by hydrolysing a synthetic fluorogenic
substrate (Fig. 1b), leading to amplification of the fluorescent signal,
as was first demonstrated in 1961 (ref. 13). However, given its
potential as a high-sensitivity cellular reporter, b-gal has an Achilles’
heel: its fluorescent products are not retained in the cell10, because
efflux pumps on the cell membrane actively and efficiently expel
LETTERS
Figure 1 | Single reporter molecule sensitivity in a microfluidic device.
a, Schematic diagram of the microfluidic chamber used for the enzymatic
assay. Cells are trapped inside a volume of 100 pl, formed by compression of
a flow channel by two control channels. b, Enzymatic amplification:
hydrolysis of the synthetic substrate FDG by the reporter enzyme b-gal
yields a fluorescent product, fluorescein. c, Differential interference contrast
(DIC) image of a microfluidic chip after actuation of the control channels.
The boundaries of one closed chamber are boxed in blue. d, DIC image of
budding yeast cells trapped in a chamber. e, f, FDG hydrolysis by purified
b-gal. e, Fluorescein concentration increases with time in chambers. The
discrete slopes are due to, in decreasing order, 3, 2, 1, 0 (autohydrolysis)
b-gal molecules. f, A histogram of hydrolysis rates (48 chambers). The red
curve is a fit to the data with three gaussians of equal widths. The peaks are
attributed to 0, 1 and 2 enzyme molecules per chamber. The distribution is
well-fitted by a Poisson distribution (black line), with an average of 0.7 b-gal
molecules per chamber.
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foreign o gan c m lecules from the ytoplasm14 (see Supplementary
Informatio ). As the fluorescent product molecules are pumped to
the surrou ding medium and rapidly diffuse away, the advantage of
enzymatic amplification is lost.
To circumvent the efflux proble , we trap cells in closed micro-
fluidic chambers, such that the fluorescent product expelled from the
cells can accumulate in the small volume of the chambers, recovering
the fluorescence signal due to enzymatic amplification. The fast
efflux rate and short mixing time of the fluorescent molecules in
the miniature chambers guarantee that the fluorescence signal
outside the cells accurately reflects the enzymatic activity inside.
The microfluidic device is made of a soft polymer, polydimethyl-
siloxane (PDMS), and consists of a flow layer that contains the cells
and a top control layer (Fig. 1a)15,16. Actuation of two adjacent valves
in the control layer forms an enclosure of dimensions
100 £ 100 £ 10 mm3 (100 pl) in which cells can be trapped and
cultured17,18 (Fig. 1c, d; see also Supplementary Fig. S1). The micro-
fluidic chip is mounted on an inverted fluorescence microscope and
translated by a motorized stage, allowing multiplexing of data
acquisition by repeatedly scanning the chambers. Typically, 100
chambers can be scanned within less than 2min. Fluorescence is
excited with a tightly focused laser beam (Fig. 1a) that does not
directly illuminate the cell, avoiding cellular autofluorescence and
photo-damage to the cell.
We first show the ability to detect single enzyme molecules using
this technique by injecting a diluted solution of purified b-gal
enzyme and 300 mM of the fluorogenic substrate fluorescein-di-b-
D-galactopyranoside (FDG) into the chambers19. Fluorescence sig-
nals from different chambers increase with time, and the slopes give
the rates of hydrolysis (Fig. 1e). The distribution of hydrolysis rates
measured in the different chambers shows quantized and evenly
spaced peaks (Fig. 1f). We attribute these discrete peaks to integer
numbers of b-gal molecules. The spacing between the peaks is
60 pMmin21, which gives a calibration for the rate of increase in
fluorescein concentration corresponding to one enzyme molecule in
a chamber.
Another challenge for using b-gal to monitor gene expression in
live cells is that he cell wall acts as a barrier for FDG influx. We
quantify this effect in E. coli by me suring the hydrolysis rate for live
cells compared to cells treated with chloroform, which completely
permeabilizes cell membrane (Supplementary Fig. S4a). The ratio of
hydrolysis rates between these two cases is defined as the permeability
ratio, and is measured to be R ¼ 13 at 300 mmFDG. To increase FDG
influx, we transformed E. coli cells with a plasmid conferring
ampicillin resistance and grew the cells in media with b-lactam
antibiotics (see Methods). Under these conditions, cell wall synthesis
is partially inhibited, making the cells more permeable to FDG,
as evident by a lower value of R ¼ 2 ^ 0.3 (Supplementary Fig. S4b).
In determining the number of enzyme molecules in live cells
below, R ¼ 2 is used as a correction factor to the in vitro calibration
(Fig. 1f).
We then monitored gene expression in live E. coli cells in real time.
b-gal is expressed from the lacZ gene on the chromosomal DNA,
which is under the control of the lac promoter. Cells are grown in
glucose-containing medium without inducer to exponential phase;
hence the expression level is highly repressed20. We observed abrupt
changes in hydrolysis rates in chambers with dividing cells, as shown
in Fig. 2a, b. These step-wise increases in the rates indicate the
stochastic burst-like expression of new b-gal molecules. We attribute
the bursts to stochastic and transient dissociation events of the Lac
repressor from the promoter, followed by transcription of mRNA,
which is then translated into a few copies of the reporter protein
before the mRNA is degraded.
The expression of proteins from a given gene can be characterized
by two key parameters: the average frequency of expression bursts per
cell cycle, a; and the average number of protein molecules per burst,
b. Under conditions of exponential growth in minimal medium, the
burst frequen y for protein expressio from the repressed E. coli lacZ
gene is measured to be a ¼ 0.11 ^ 0.03 bursts per cell cycle. The
average burst siz is me sured to be b ¼ 5 ^ 2 enzymes, or 20 ^ 8
monomers per urst, which is consistent with biochemical estimates
of 25–30 b-gal monomers per mRNA21,22.
This real-time assay also allows us to measure the distribution of
the number of enzymes produced per burst (Fig. 2c). It can be well
fitted with an exponential distribution, PðnÞ ¼ C expð2n=bÞ, where n
is the number of b-gal molecules per burst and C is a normalization
constant. We attribute this distribution to the fact that the cellular
lifetime of the mRNA is exponentially distributed21,23. Previously
only theoretically predicted1,24, the exponential P(n) can be
accounted for by the competition between mRNA degradation by
Figure 2 | Quantitative real-time measurement of individual protein
expression events in live E. coli cells. b-gal is under the control of a
repressed lac promoter. a, Trace of a chamber containing dividing cells
shows abrupt changes in hydrolysis rates (arrows on black curve). An empty
chamber shows a constant background (red curve). b, Discrete jumps in
b-gal number are due to burst-like production of proteins. The number of
b-gal molecules is calculated by taking the time derivative of the traces in a
and compensating for fluorescein photobleaching (Supplementary
Information). c, Histogram of copy number of b-gal molecules per burst.
The distribution is well-fitted with an exponential function (black line), with
an average of five proteins per burst, and is a consequence of exponential
cellular lifetime of the mRNA.
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foreign organic molecules from the cytoplasm14 (see Supplementary
Information). As the fluorescent product molecules are pumped to
the surrounding medium and rapidly diffuse away, the advantage of
enzymatic amplification is lost.
To circumvent the efflux problem, we trap cells in closed micro-
fluidic chambers, such that the fluorescent product expelled from the
cells can accumulate in the small volume of the chambers, recovering
the fluorescence signal due to enzymatic amplification. The fast
efflux rate and short mixing time of the fluorescent molecules in
the miniature chambers guarantee that the fluorescence signal
outside the cells accurately reflects the enzymatic activity inside.
The microfluidic device is made of a soft polymer, polydimethyl-
siloxane (PDMS), and consists of a flow layer that contains the cells
and a top control layer (Fig. 1a)15,16. Actuation f two adjacent valves
in the control layer forms n enclosure of dim nsions
100 £ 100 £ 10 mm3 (100 pl) in which cells ca be trapped an
cultured17,18 (Fig. 1c, d; se also Suppl mentary Fig. S1). The micro-
fluidic chip is mounted on an inverted fluorescence microscope and
translated by a motorized stage, allowing multiplexing of data
acquisition by repeatedly scanning the chambers. Typically, 100
chambers can be scanned within less than 2min. Fluorescence is
excited with a tightly focus d laser be m (Fig. 1a) th t does not
directly illuminate the cell, avoiding cellular autoflu rescence an
photo-damage to the cell.
We first sh w the ability to detect single enzyme m lecul s using
this technique by injecting a diluted solution of purified b-gal
enzyme and 3 mM of the fluorogenic substrate fluorescein- i-b-
D-galactopyranoside (FDG) into the chambers19. Fluorescence sig-
nals from different chambers increase with time, and the slopes give
the rates of hydrolysis (Fig. 1e). The distribution of hydrolysis rates
measured in the different chambers shows quantized and evenly
spaced peaks (Fig. 1f). We attribute these discrete peaks to integer
numbers of b-gal molecules. The spacing between the peaks is
60 pMmin21, which gives a calibration for the rate of increase in
fluorescein concentration corresp nding to one enzyme molecule
a chamber.
Another challenge for using b-gal t monitor gene expression in
live cells is that the cell wall acts as a barrier for FDG influx. We
quantify this effect in E. coli by measuring the hydrolysis rate for live
cells compared to cells treated with chloroform, which completely
permeabilizes cell membrane (Supplementary Fig. S4a). The ratio of
hydrolysis rates between these two cases is defined as the permeability
ratio, and is measured to be R ¼ 13 at 300 mmFDG. To increase FDG
influx, we transformed E. coli c lls with a plasmid conf rring
ampicillin resistance and grew the cells in media with b-lactam
antibiotics (see Methods). Unde these onditi ns, cell wall synthesis
is partially inhibited, making the cells more perm abl t FDG,
as evident by a lower value of R ¼ 2 ^ 0.3 (Supplementary Fig. S4b).
In determining the number of enzyme molecules in live cells
below, R ¼ 2 is used as a correction factor to the in vitro calibration
(Fig. 1f).
We then monitored gene expression in live E. coli cells in real time.
b-gal is expressed from the lacZ gen on the chromosomal DNA,
which is under the control of the lac promoter. Cells are grown in
glucose-containing medium withou inducer t expon ntial phase;
hence the expression lev l is highly repressed20. We observed abrupt
changes in hydrolysis rates in chambers with dividing cells, as shown
in Fig. 2a, b. These step-wise increases in the rates indicate the
stochastic burst-like expression of new b-gal molecules. We attribute
the bursts to stochastic and transient dissociation events of the Lac
repressor from the promoter, followed by transcription of mRNA,
which is then translated into a few copies of the reporter protein
before t e mRNA is degraded.
The expression of proteins from a given gene can be characterized
by two key parameters: th av rage frequency of expression bursts per
cell cycle, a; and the average number of protein olecules per burst,
b. Under conditions of exponential growth in minimal medium, the
burst frequency for protein expression from the repressed E. coli lacZ
gene is measured to be a ¼ 0.11 ^ 0.03 bursts per cell cycle. The
average burst size is measured to be b ¼ 5 ^ 2 enzymes, or 20 ^ 8
monomers per burst, which is consistent with biochemical estimates
of 25–30 b-gal monomers per mRNA21,22.
This real-time assay also allows us to measure the distribution of
the number of enzymes produced per burst (Fig. 2c). It can be well
fitted with an exponential distribution, PðnÞ ¼ C expð2n=bÞ, where n
is the number of b-gal molecules per burst and C is a normalization
constant. We attribute this distribution to the fact that the cellular
lifetime of the mRNA is exponentially distributed21,23. Previously
only theoretically predicted1,24, the exponential P(n) can be
accounted for by the competition between mRNA degradation by
Figure 2 | Quantitative real-time measurement of individual protein
expression events in live E. coli cells. b-gal is under the control of a
repressed lac promoter. a, Trace of a chamber containing dividing cells
shows abrupt changes in hydrolysis rates (arrows on black curve). An empty
chamber shows a constant background (red curve). b, Discrete jumps in
b-gal number are due to burst-like production of proteins. The number of
b-gal molecules is calculated by taking the time derivative of the traces in a
and compensating for fluorescein photobleaching (Supplementary
Information). c, Histogram of copy nu ber of b-gal molecules per burst.
The distribution is well-fitted with an exponential function (black line), with
an average of five proteins per burst, and is a consequence of exponential
cellular lifetime of the mRNA.
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foreign organic molecules from the cytoplasm14 (see Supplementary
Information). As the fluorescent product molecules are pumped to
the surrounding medium and rapidly diffuse away, the advantage of
enzymatic amplification is lost.
To circumvent the efflux problem, we trap cells in closed micro-
fluidic chambers, such that the fluorescent product expelled from the
cells can accumulate in the small volume of the chambers, recovering
the fluorescence signal due to enzymatic amplification. The fast
efflux rate and short mixing time of the fluorescent molecules in
the miniature chambers guarantee that the fluorescence signal
outside the cells accurately reflects the enzymatic activity inside.
The microfluidic device is made of a soft polymer, polydimethyl-
siloxane (PDMS), and consists of a flow layer that contains the cells
and a top control layer (Fig. 1a)15,16. Actuation of two adjacent valves
in the control layer forms an enclosure of dimensions
100 £ 100 £ 10 mm3 (100 pl) in which cells can be trapped and
cultured17,18 (Fig. 1c, d; see also Supplementary Fig. S1). The micro-
fluidic chip is mounted on an inverted fluorescence microscope and
translated by a motorized stage, allowing multiplexing of data
acquisition by repeatedly scanning the chambers. Typically, 100
chambers can be scanned within less than 2min. Fluorescence is
excited with a tightly focused laser beam (Fig. 1a) that does not
directly illuminate the cell, avoiding cellular autofluorescence and
photo-damage to the cell.
We first show the ability to detect single enzyme molecules using
this technique by injecting a diluted solution of purified b-gal
enzyme and 300 mM of the fluorogenic substrate fluorescein-di-b-
D-galactopyranoside (FDG) into the chambers19. Fluorescence sig-
nals from different chambers increase with time, and the slopes give
the rates of hydrolysis (Fig. 1e). The distribution of hydrolysis rates
measured in the different chambers shows quantized and evenly
spaced peaks (Fig. 1f). We attribute these discrete peaks to integer
numbers of b-gal molecules. The spacing between the peaks is
60 pMmin21, which gives a calibration for the rate of increase in
fluorescein concentration corresponding to one enzyme molecule in
a chamber.
Another challenge for using b-gal to monitor gene expression in
live cells is that the cell wall acts as a barrier for FDG influx. We
quantify this effect in E. coli by measuring the hydrolysis rate for live
cells compared to cells treated with chloroform, which completely
permeabilizes cell membrane (Supplementary Fig. S4a). The ratio of
hydrolysis rates between these two cases is defined as the permeability
ratio, and is measured to be R ¼ 13 at 300 mmFDG. To increase FDG
influx, we transformed E. coli cells with a plasmid conferring
ampicillin resistance and grew the cells in media with b-lactam
antibiotics (see Methods). Under these conditions, cell wall synthesis
is partially inhibited, making the cells more permeable to FDG,
as evident by a lower value of R ¼ 2 ^ 0.3 (Supplementary Fig. S4b).
In determining the number of enzyme molecules in live cells
below, R ¼ 2 is used as a correction factor to the in vitro calibration
(Fig. 1f).
We then monitored gene expression in live E. coli cells in real time.
b-gal is expressed from the lacZ gene on the chromosomal DNA,
which is under the control of the lac promoter. Cells are grown in
glucose-containing medium without inducer to exponential phase;
hence the expression level is highly repressed20. We observed abrupt
changes in hydrolysis rates in chambers with dividing cells, as shown
in Fig. 2a, b. These step-wise increases in the rates indicate the
stochastic burst-like expression of new b-gal molecules. We attribute
the bursts to stochastic and transient dissociation events of the Lac
repressor from the promoter, followed by transcription of mRNA,
which is then translated into a few copies of the reporter protein
before the mRNA is degraded.
The expression of proteins from a given gene can be characterized
by two key parameters: the average frequency of expression bursts per
cell cycle, a; and the average number of protein molecules per burst,
b. Under conditions of exponential growth in minimal medium, the
burst frequency for protein expression from the repressed E. coli lacZ
gene is measured to be a ¼ 0.11 ^ 0.03 bursts per cell cycle. The
average burst size is measured to be b ¼ 5 ^ 2 enzymes, r 20 ^ 8
monomers per burst, which is consistent with biochemical estimates
of 25–30 b-gal mon mers per mRNA21,22.
This real-time assay also allows us to measure t di ribution of
the number of enzymes produced per burs (Fig. 2c). It can be well
fitted with an exponential distribution, PðnÞ ¼ C expð2n=bÞ, where n
is the number of b-gal molecules per burst and C is a normalization
constant. We attribute this distribution to the fact that the cellular
lifetime of the mRNA is exponentially distributed21,23. Previously
only theoretically predicted1,24, the exponential P(n) can be
accounted for by the competition between mRNA degradation by
Figure 2 | Quantitative real-time measurement of individual protein
expression events in live E. coli cells. b-gal is under the control of a
repressed lac promoter. a, Trace of a chamber containing dividing cells
shows abrupt changes in hydrolysis rates (arrows on black curve). An empty
chamber shows a constant background (red curve). b, Discrete jumps in
b-gal number are due to burst-like production of proteins. The number of
b-gal molecules is calculated by taking the time derivative of the traces in a
and compensating for fluorescein photobleaching (Supplementary
Information). c, Histogram of copy number of b-gal molecules per burst.
The distribution is well-fitted with an exponential function (black line), with
an average of five proteins per burst, and is a consequence of exponential
cellular lifetime of the mRNA.
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Figure 1.3: P otei production burst statistics. Reprinted by permission from
Macmilla Publishers Ltd: Nature [16], copyright (2006). (A) The microfluidic
experimental apparatus. (B) Real time measurement of fluorescein per micro-
well. (C) β-galactosidase hydrolysis of FDG into galactose and fluorescein. (D)
Real time measurements of abundance of β-gal per micro-well. (E) Histogram of
β-gal protein produced per burst and the corresponding exponenti l fit.
is a stochastic processes, and that the magnit d of the resulting pr tein d versity
i tunable by both the kineti p rameters of gene expression and the structure of
g ne regulatory networks.
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1.4 Stochastic gene expression correlates with phenotypic
variability
The intrinsic stochasticity of gene expression is an elegant mechanism proposed to
generate the behavioral individuality observed in both prokaryotes and eukaryotes.
Indeed, numerical simulations of gene regulatory network activity suggest that the
stochastic expression of protein is sufficient to generate variable biological behav-
iors. For example, simulations of gene expression in E. coli infected with phage λ
accurately predicted the fraction of cells exhibiting either lysogenic or lytic phe-
notypes [6]. Moreover, diversity originating from the stochastic accumulation of
IL2Rα was sufficient in generating diverse times of cell cycle entry in T lympho-
cytes [87]. Additionally, the stochasticity in gene expression in mouse Embryonic
Stem cells generated variability in the dynamics of the Oct4, Sox2, and Nanog
gene regulatory network. This variability was shown to give rise to a transient
Nanog low state capable of differentiation [42]. Indeed, these results suggest that
gene expression variability is sufficient to generate unique biological behaviors, yet
they do not provide unequivocal evidence for this mechanism. In this section we
present an examples in which biological individuality is generated by the diversity
of protein products.
Korobkova et al. [48] measured bacterial chemotactic response with real time
single cell measurements of flagellar activity in engineered strains of E. coli. Here,
they monitored the rotation preferences, clockwise (CW) or counter-clockwise
(CCW), of individual and immobilized E. coli as a measure of the chemotactic
signaling pathway response. The temporal data were then encoded in binary (CW
or CCW) and were characterized by the the corresponding power spectrum. The
power spectrum is a sensitive measure of the magnitude of correlations at different
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frequencies, inverse time lags. Strikingly, they observed that the power spectrum
of unstimulated E. coli flagellar motion peaked at 10−3 Hz, a large deviation from
the timescale representative of the Poisson process (0.1Hz - 1 Hz) of this network
of chemical reactions. Indeed, these fluctuations arise from the complex nonlinear
properties of the molecular reactions in this network. Interestingly, they found
that by changing the internal concentration of the regulator CheR, they were able
to tune the correlation timescale of the bacteria. If we consider a population of
clones of bacteria, the stochastic production of CheR would tune their respective
CW biases. Unique CW biases would macroscopically manifest as unique individ-
ual response times to stimulus as first observed by Spudich and Koshland [77].
Another important behavior of cells is the transient switching of differentia-
tion states. Su¨el et al. [79], demonstrated that the bacteria B subtilis utilizes the
fluctuations of protein to transiently switch from a vegetative state to a transient
competent state. In this system the switch to a competent state occurs upon
upregulation of the master regulator ComK and its corresponding gene products.
comK is constitutively expressed at low levels during the stationary phase of the
bacteria, but can’t initiate competency due to MecA catalyzed degradation of the
protein. ComS, another protein involved in this gene regulatory network functions
as an inhibitor of MecA (Figure 1.4A), and as a result ComK increases and initiates
competency. To understand how these complex dynamics manifest into a transient
differentiation state, Su¨el et al concomitantly monitored the fluorescence of CFP
and YFP by quantitative fluorescence microscopy in individual bacteria. cfp ex-
pression was upregulated by the presence of ComK, meanwhile yfp expression was
controlled by the abundance of ComS. Figure 1.4B shows the resulting dynamics
of these two fluorescent proteins in a single bacteria. Here, we see that the dynam-
ics of ComK follow those of ComS and as a result exhibit staggered limit cycles.
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Combining these observations and the interactions of the gene regulatory network
structure they built a nonlinear dynamical model of ComS and ComK abundance.
The corresponding dynamics of this model are summarized by the phase plane in
Figure 1.4C. In this figure we see that the nullclines representing the stationary
dependency of ComK (blue) and ComS (green) cross in three places, and represent
three stationary or fixed points in the dynamical system. The system rests in the
vegetative state which is represented by the stable fixed point (filled circle). How-
ever, upon experiencing a large fluctuation in the expression of comS, the system
must cycle about the remaining two unstable fixed points (open circles) to return
to the stable fixed point. This transient and stochastically induced cycle represents
the transition to the transient competent state. Indeed, the stochastic expression
of protein was required to initiate the dynamics of competency.
17
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Figure 2 | Activities of PcomK and PcomG promoters are highly correlated
during competence. a, Frames from film footage of a typical competence
event. yfp expressed from PcomK and cfp expressed from PcomG are coloured
blue and red, respectively (see also Supplementary Movie 1). Overlapping
dynamics of PcomK and PcomG result in the purple (red plus blue) colour of
the competent cell. Time (in hours) is indicated for each frame. b,
Quantitative time series of PcomK–yfp (blue line) and PcomG–cfp (red line)
obtained through semi-automated data processing of the competence event
shown in a. PcomK and PcomG activities exhibit nearly identical dynamics. a.u.,
arbitrary units. c, Plot of PcomK–yfp versus PcomG–cfp obtained from all
(n ¼ 37) competence events in this strain. The traces are smoothed for
visual clarification. Note the positive correlation between PcomK–yfp and
PcomG–cfp. Highlighted in black is the competence time trace depicted in b.
Figure 3 | Promoter activities of PcomS and PcomG are anti-correlated during
competence. a, Frames from film footage of a typical competence event
with PcomS–yfp and PcomG–cfp expression shown in green and red,
respectively (see inset) (see also SupplementaryMovie 2). Time (in hours) is
indicated for each frame. b, Quantitative time series of PcomS–yfp (green line)
and PcomG–cfp (red lines) for the competence event shown in a. Depicted in
faint green and faint red are PcomS and PcomG activities obtained from the
non-competent sister cell. Note that the negative correlation between PcomS
and PcomG expression dynamics is only observed in the competent cell.
c, Plot of PcomS–yfp versus PcomG–cfp obtained from all (n ¼ 31) competence
events in this strain. The traces are smoothed for visual clarification. Note
the negative correlation between PcomS–yfp and PcomG–cfp. Highlighted in
black is the competence time trace depicted in b. d, Quantitative time traces
of consecutive competence events within a single cell lineage. The colour
scheme is identical to that described for b. e, Quantitative time traces of
PcomS–yfp and PcomG–cfp measured in sister cells that both undergo
competence. The colour scheme is identical to that described for b. Note the
different durations of competence in sister cells (see Supplementary Fig. S7).
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Figure 4 | Modelling of the core competence network reveals an excitable
system. a, Phase plane diagram formed by the system of equations shown in
Box 1. Nullclines for equations (1) and (2) are shown in blue and green,
respectively. Grey arrows represent the vector field of the dynamical system.
The stable steady-state corresponding to vegetative growth is indicated with a
black filled circle. The saddle and the unstable competent fixed points are
indicated with open circles. A set of excursion trajectories is shown in pink,
with a single representative trajectory of the system highlighted in purple.
Initiation of excursions in phase space is triggered by noise (Box 1), and
trajectories are determined by the phase space vector field. b, Simulations of
ComS (green) and ComK (blue) activities as a function of time. Note the
negative correlation between the ComS and ComK levels during competence,
consistent with experimental observations.
Figure 5 | Competence lock through feedback
bypass. a, Network schematic depicting in blue
the extra link introduced to bypass the native
ComS-mediated negative feedback loop (FeBy
strain). Note that the native network is left intact
(see Fig. 1a). b, Frames from film footage of a
typical competence event in the FeBy strain, with
PcomS and PcomG activities depicted in green and
red, respectively (see also Supplementary
Movie 3). c, Quantitative time series of PcomS–yfp
(green line) and PcomG–cfp (red line) for the event
shown in b. The FeBy cell enters competence, but
cannot exit from competence and eventually lyses
(note the sudden drop after nearly 80 h).
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of comS is, however, known to be complex, having several transcrip-
tional inputs (Supplementary Fig. S1)19–21. To test the prediction of
the MeKS model we constructed a strain containing copies of the
PcomG and PcomS promoters expressing cfp and yfp, respectively. As
shown in Fig. 3a and SupplementaryMovie 2, all cells express PcomS to
varying degrees. In cells that become competent, PcomG activity
increases as PcomS activity decreases. Later, as PcomG activity shuts
off and septation begins, PcomS activity increases again. This striking
negative correlation between PcomG and PcomS activities is present
during both entry and exit from competence, although it is more
closely synchronized during entry (Fig. 3b). This behaviour is
representative of data obtained from all competent cells of the
same strain (n ¼ 31) (Fig. 3c), and is consistent with negative
regulation of comS by ComK. Furthermore, the negative correlation
is specific to competence, as is evident from the behaviour of the
non-competent sister cell in Fig. 3b.
A fundamental question is whether initiation of competence is
stochastic or affected by memory of previous events. Escape from
competence returns promoter activities to pre-competence levels,
suggesting the possibility of successive episodes of competence.
Indeed, as shown in Fig. 3d, two consecutive competence events
can be observed in a single cell lineage, showing that cells retain the
potential to re-initiate competence. In fact, re-initiation occurred
with a frequency of 6.0 ^ 2.0% (n ¼ 9 events out of 151), not
significantly different from the overall competence frequency
(3.6 ^ 0.7%). Repeated competence events are neither favoured
nor suppressed. This evide ce for stochastic ini iation of competence
is further supported by analysis of competence events in sister cell
pairs (Supplementary Information). Cells were not significantly
more or less likely to become competent if their sister became
competent (conditional frequency ¼ 4.1 ^ 0.9%, n ¼ 19 events
out of 463). When two sisters do become competent together, the
amount of time one spends in competence is uncorrelated with that
of its sister cell (Kolmogorov–Smirnov test; n ¼ 36). These results are
consistent with a stochastic and memory-less model for competence
initiation and duration.
Figure 1 | Stress response in B. subtilis and the core competence circuit.
a, Snapshot of a B. subtilis microcolony in nutrient-limited conditions. cfp
expression from PcomG is shown in red. Inset: a flow chart illustrating
developmental paths connecting the vegetative, spore forming and
competent states. b, Map of interactions within the core competence circuit
(MeKS). The transcriptional autoregulatory positive feedback loop of ComK
and the ComS-mediated indirect negative feedback loop are depicted in
orange and purple, respectively. ComS competes with ComK for degradation
by the MecA–ClpP–ClpC complex, effectively interfering with degradation of
ComK (curved purple inhibitory arrow). The dashed purple line f om ComK
toPcomSdenotes indirect repression. The activities of the promoters labelled in
red, blue and green were measured in this study. These colours are used to
represent the corresponding promoters throughout the figures.
Box 1 |The dynamical model of competence induction
To understand how the MeKS network structure determines the
dynamics of competence, we built a mathematical model
constrained by experimental observations (see Supplementary
Information). This model can be reduced to a system of two
stochastic ordinary differential equations incorporating both the
direct positive and the ComS-mediated negative feedback loops of
ComK. In dimensionless form:
dK
dt
¼ akþ bkK
n
kn0 þKn
2
K
1þKþ S ð1Þ
dS
dt
¼ bs
1þ K=k1
! "p2 S1þKþ Sþ yðtÞ ð2Þ
Here, K and S represent the concentration levels of ComK and ComS
protein, respectively. ak and bk represent minimal and fully activated
rates of ComK production, respectively. k0 is the concentration of
ComK required for 50% activation. The cooperativities of ComK
auto-activation and ComS repression are parameterized by the Hill
coefficients n and p, respectively. Expression of ComS has maximum
rate bs and is half-maximal when K ¼ k 1. Enzymatic MecA-mediated
degradation affects both ComK and ComS; the form of the
corresponding nonlinear degradation terms expresses a competitive
mechanism, which is the only source of coupling from ComS to
ComK. Random fluctuations in ComS expression are represented by
a noise term y(t) (see Supplementary Information for a more
detailed analysis).
The dynamical behaviour of equations (1) and (2) without noise
can be analysed graphically by plotting their nullclines and vec or
field in the ComK–ComS phase space (Fig. 4a) for appropriate
parameters (given in the Supplementary Information). This analysis
reveals three fixed points: a stable node at low ComK (the
vegetative state) and two unstable fixed points. Of these, the one at
intermediate ComK is an unstable saddle and the one at high ComK
(the competent state) is an unstable spiral. No limit-cycle behaviour
coexists with the stable vegetative state in this parameter region
(see Supplementary Information). Under these conditions, the
system is capable of excitable behaviour: relatively small
perturbations from the vegetative state may cause long excursions
through phase space around the unstable spiral at high ComK (that
is, through the competence region), as determined by the vector
field. The vegetative state can be perturbed by noise in the
expression of either ComK or ComS, leading to these transient
differentiation events. Samples of such trajectories, generated by
numerical integration of the model, are superimposed as pink lines
in Fig. 4a and plotted against time in Fig. 4b.
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Figure 1.4: Excitable g e re ulat ry network controls transient differ-
entiation. Reprinted by pe ission from Macmillan Publishers Ltd: Nature [79]
copyright (2006). (A) The simplified gene regulatory n twork controlling the tran-
sient competent state in B subtilis. (B) The dynamics of ComK (CFP) and C mS
(YFP) abundance in a single cell. cfp and yfp expression was encoded under
promoters activated by ComK and ComS, respectively. (C) The phase diagram
summarizing the dynamics of ComK and ComS. Blue and green lines represent the
nullclines from the dynamic equations of ComK and ComS, respectively. The pur-
ple line represents a single representative competency cycle. Pink lines are samples
of stochastic trajectories in the ComK, ComS plane. The arrows show the relative
strengths of the velocity field.
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1.5 In this dissertation
Single cell measurements have revealed that biological systems are diverse and com-
plex. In many cases this diversity is driven by the stochastic behavior of chemical
reactions in the limit of small numbers of molecules. Exacerbating these statisti-
cal fluctuations in molecular abundance of biochemicals are the complex nonlinear
processes they compose, often capable of explosive amplification from small differ-
ences in initial conditions. Because, these phenomena are general properties of the
tools at the disposal of cells it is imperative to theoretically understand the space
of possible solutions these systems can explore and validate predictions with exper-
iments at the appropriate resolution, the single cell. In this dissertation I present
work, done in collaboration with colleagues at Memorial Sloan Kettering Cancer
Center and at IBM, that aims in providing insight to properties of stochastic bio-
logical process (e.g. gene expression and phospho-signaling) and the consequences
of diversity and nonlinear structure in chemical inhibition.
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CHAPTER 2
PROPAGATION OF FLUCTUATIONS IN THE ABUNDANCE OF
BIOMOLECULES
Cells make decisions in response to environmental stimuli by using systems
of biochemical reactions. These reactions are required to quickly infer the cell’s
environmental state, and translate that information into an executable cellular
program. Successful execution of a program consists of activating the optimal set
of genes required for the desired response. The accurate response to the environ-
ment is predicated on accurate processing by the network of biochemical reactions.
However, these reactions are subject to randomness introduced by the discrete na-
ture of molecules. Indeed, simulations of chemical reactions with small numbers of
reactants manifest in products that fluctuate in their concentration [84, 34, 35]. In
these simulations one assumes that the fluctuations are exclusively attributed to
the infrequent random collisions of molecules of well mixed idealized systems. Cel-
lular systems are often the opposite; they are crowded, not well mixed, and do not
always consist of a small number of molecules. Consequently, several pioneering
studies have shown how biological systems exhibit noisy processing beyond that
predicted by Poisson processes [82, 33, 16]. However, there is no systematic analy-
sis of the transmission of fluctuations in the abundance of biomolecules originating
from such observed diversity.
In this chapter I present a study of biochemical noise conducted in collaboration
with members of IBM T.J. Watson Research Center [66]. Our goal was to develop a
framework to infer the structure of the biochemical network that generates a mea-
sured response to perturbation by analyzing the fluctuations (so-called noise) in
protein abundance at steady state. In this study we characterized the fluctuations
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in the abundance of biomolecules in two biological systems: 1) gene expression
in a synthetic gene regulatory network in E. coli measured and previously pub-
lished by Pedraza and van Oudenaarden [64], and 2) in the phospho-signaling of
primary T lymphocytes. We used single cell measurements of protein and phospho-
signal abundance to identify the steady state distribution which the fluctuations
are sampled from. Using our experimentally motivated distribution we developed
a chemical Langevin equation and investigated the properties of the fluctuations
in biochemical abundance with respect to three network configurations. Lastly,
we used our framework to infer the underlying network configuration associated
with signal propagation in our experimental system. We used the consistency of
our experimental findings with current understanding of the biological systems un-
der study (by design, for the synthetic circuit; by common understanding, for the
signal transduction cascade) to validate our approach.
2.1 Fluctuations in biochemical abundance is log-normal
In this section, we introduce the two biological systems we investigated, at the
single cell level, in order to tease out the role and significance of biochemical
fluctuations.
2.1.1 Fluctuations in a synthetic E. coli gene regulatory
network
Pedraza and van Oudenaarden [64] developed a simple synthetic gene regulatory
network to measure the propagation of protein fluctuations from one gene to an-
other in Escherichia coli. This network utilized four genes designated Gene 0 (G0),
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Gene 1 (G1), Gene 2 (G2) and lastly Gene 3 (G3). In this small network G0 in-
hibits the expression of G1, G1 inhibits the expression of G2, and G3 does not
interact with either of the genes (Figure 2.1). As a result, any correlation of the
abundance of Genes 0,1,2 with Gene 3 originate from extrinsic sources of variability
(e.g. variability in plasmid copies per cell). To eliminate this source of variability,
we normalized the fluorescence representing the abundance of Gene 1 and Gene 2
in each cell by that of Gene 3.
the control of the lambda repressor promoter
PL, which is a strong constitutive promoter.
Because this gene is not part of the cascade,
this reporter was used to evaluate the effect
of global fluctuations. This cascade was used
to measure how fluctuations in an upstream
gene (tetR, reported by CFP) transmit down-
stream (and are reported by YFP). The inducers
isopropyl-b-D-thiogalactopyranoside (IPTG)
and anhydrotetracycline (ATC) bind to and
inhibit the repression of the lactose and tetra-
cycline repressors, respectively, and were
used to tune, respectively, the expression of
the upstream gene and the coupling between
the two genes.
We assayed the response of single cells to
various amounts of inducers by using auto-
mated fluorescence microscopy. In each exper-
imental run, the level of the three fluorescent
reporters was quantified for È2000 individual
cells. Figure 1B shows that the average signal
of the upstream gene displayed a sigmoidal
response to changes in the concentration of
IPTG in the growth media. In response, the av-
erage signal of the downstream gene (Fig. 1C)
behaved inversely and decreased sharply at
larger IPTG concentrations. The enhanced sen-
sitivity of the YFP response, compared to the
CFP response, when IPTG is varied demon-
strates the utility of cascades for generating
steep switches (7–10). However, the average
expression alone does not capture the pop-
ulation behavior, because the expression of
most cells is quite different from the average
(Fig. 1D). Even for a fixed IPTG concentra-
tion, the fluctuations in gene expression re-
sulted in a broad distribution that reflects the
interaction between the upstream and down-
stream genes.
To quantify the expression fluctuations
and the degree of correlation between differ-
ent genes, we computed the correlation
Fig. 1. (A) A schematic design of the network. (B and C) Average CFP and
YFP expression as a function of IPTG concentration in the steady state.
Each experimental data point was obtained from È2000 single-cell mea-
surements. The solid lines are fits obtained from the Langevin model
(23). (D) Scatter plot of the fluorescence levels for the entire popu-
lation at [IPTG] 0 13 mM. This corresponds to the points marked by the
arrows in (B) and (C). The red lines indicate the average CFP and YFP
expression.
Fig. 2. (A to C) Coefficient of variation h i 0
ﬃﬃﬃﬃﬃ
Cii
p
of the expression in genes 1 to 3 as a function of
IPTG concentration in the steady state. (D to F) Correlation between the expression levels of genes 1
and 2, 1 and 3, and 2 and 3, respectively. The solid lines are predictions from the Langevin model (23).
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Figure 2.1: Synthetic E. coli gene network. From [64]. Reprinted with per-
mission from AAAS. The synthetic gene regulatory network developed by Pedraza
and van Oudenaarden.
The first three genes in the network form a cascade of negative regulators (Fig-
ure 2.1). The first gene in the cascade, G0, constitutively expresses the lacI gene
which encodes the lactose repressor, an inhibitor of the lac promoter. In the ab-
sence of lactose, or the lactose analog isopropyl-β-D-thiogalactopyranoside (IPTG),
the lac repressor inhibits the transcription of G1. As a result, the exogenous ad-
ministration of IPTG provides an experimental tool for tuning the activity of t e
network. G1 encodes for both tetR and cfp genes, which encode for the tetracycline
repressor and the cyan fluorescent protein (CFP), respectively. Continuing down
the cascade, the tetracycline repressor inhibits the activation of the tetracycline
promoter, which in turn controls the transcription of G2 and con qu ntly th
abundance of the yellow fluorescent protein (YFP). The inhibitory capacity of the
tetracycline repressor can be modulated by the administr tion of exogenous an-
hydrotetracycline (ATC), however we do not investigate the consequences of ATC
administration.
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The fluctuations of protein abundance for each gene product pair (CFP, YFP)
were monitored in individual E. coli cells by fluorescent microscopy. Measurements
were taken for various doses of IPTG treatment, after the gene expression dynamics
reached steady state. Preliminary analysis of the fluctuations demonstrated that
the distribution of G1 (CFP) is best described by a Gaussian of the logarithmic
(Figure 2.2A, left) and not the linear abundance of protein (Figure 2.2A, right).
Indeed, a Wilcoxon signed-rank test confirmed that the respective errors in the
fit were not sampled from identical distributions (p = 0.0013), and the that the
sum-squared errors was approximately four-fold lower for the log-normal fit. In ad-
dition, concomitant monitoring of G1 (CFP) and G2 (YFP) abundance for various
doses of IPTG demonstrated that the joint distribution of gene products can be
approximated by a bivariate Gaussian of the logarithmic protein abundance (Fig-
ure 2.2B-D). As a result, stochastic equations representing the dynamics of gene
expression need to incorporate log-normally distribution fluctuations of protein
abundance.
2.1.2 Noise in mammalian signal transduction
We characterized the fluctuations in phosphorylated protein abundances in the Mi-
togen Activated Protein Kinase (MAPK) cascade. The canonical MAPK cascade
consists of a series of biochemical reactions, many of which involve the transfer of
a phosphate group from ATP to specific amino acid residues of the down stream
target protein by its parent kinase. The cascade involves the initial activation of
MAPKKK, which processively phosphorylates MAPKK two times, which in turn,
processively adds two phosphates to MAPK [39], (Figure 2.3). We measured the
progression of signal through the MAPK pathway using monoclonal antibodies
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Figure 2.2: Log-normally distributed protein in E. coli. (A) Gaussian dis-
tribution fits to the distribution of G1 gene product (CFP) in log (right) and
linear (left) scale. Single cell measurements of G1 (CFP) and G2 (YFP) for (B) a
saturating dose, (C) intermediate dose, and (D) an ineffective dose of IPTG.
specific for the phosphorylated MEK 1/2 (p-Serine 221, MAPKK) and doubly
phosphorylated ERK 1/2 (p-Threonine 202, p-Tyrosine 204, MAPK) in primary
5CC7 mouse CD4+ T lymphocytes (T cells) by Flow Cytometry.
To stimulate the MAPK cascade in T cells we administered various doses of the
small molecule phorbol 12-myristate 13-acetate (PMA). PMA activates the MAPK
pathway by activating DAG-PKC-RasGRP signaling axis, which directly activates
RAF followed by phosphorylating MEK (pMEK) and lastly phosphorylating ERK
(ppERK) [24]. We measured the cells after ten minutes of stimulation, a sufficiently
24
Proc. Natl. Acad. Sci. USA 
Vol. 93, pp. 10078-10083, September 1996 
Biochemistry 
Ultrasensitivity in the mitogen-activated protein kinase cascade 
CHI-YING F. HUANG AND JAMES E. FERRELL, JR.t 
Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, CA 94305-5332 
Communicated by Daniel E. Koshland, Jr., University of California, Berkeley, CA, May 16, 1996 (received for review January 22, 1996) 
ABSTRACT The mitogen-activated protein kinase 
(MAPK) cascade is a highly conserved series of three protein 
kinases implicated in diverse biological processes. Here we 
demonstrate that the cascade arrangement has unexpected 
consequences for the dynamics of MAPK signaling. We solved 
the rate equations for the cascade numerically and found that 
MAPK is predicted to behave like a highly cooperative en- 
zyme, even though it was not assumed that any of the enzymes 
in the cascade were regulated cooperatively. Measurements of 
MAPK activation in Xenopus oocyte extracts confirmed this 
prediction. The stimulus/response curve of the MAPK was 
found to be as steep as that of a cooperative enzyme with a Hill 
coefficient of 4-5, well in excess of that of the classical 
allosteric protein hemoglobin. The shape of the MAPK stim- 
ulus/response curve may make the cascade particularly ap- 
propriate for mediating processes like mitogenesis, cell fate 
induction, and oocyte maturation, where a cell switches from 
one discrete state to another. 
Although the biological responses associated with mitogen- 
activated protein kinase (MAPK) signaling are highly varied, 
the basic structure of the MAPK cascade is well conserved 
(1-3). The cascade always consists of a MAPK kinase kinase 
(MAPKKK), a MAPK kinase (MAPKK), and a MAPK. 
MAPKKKs activate MAPKKs by phosphorylation at two 
conserved serine residues and MAPKKs activate MAPKs by 
phosphorylation at conserved threonine and tyrosine residues 
(Fig. 1). The cascade relays signals from the plasma membrane 
to targets in the cytoplasm and nucleus. 
A number of other membrane-to-nucleus signaling pathways, 
such as the Jak/Stat pathways and the cAMP/protein kinase A 
pathway, employ just a single protein kinase. Why does the 
MAPK cascade invariably use three kinases instead of one? The 
possibility that the three kinase arrangement has evolved to allow 
signal ramification or amplification is attractive but, as yet, not 
well supported by genetic or biochemical evidence. 
We have explored the possibility that the cascade arrangement 
has important consequences for the dynamics of MAPK signal- 
ing. Here we shall focus on the steady-state responses of enzymes 
at each level in the cascade to varying input stimuli. The stimulus/ 
response curve of a typical Michaelis-Menten enzyme is hyper- 
bolic, and the enzyme responds in a graded fashion to increasing 
stimuli. An 81-fold increase in stimulus is needed to drive the 
enzyme from 10% to 90% maximal response (see for example, 
the MAPKKK curves in Fig. 2). However, some enzymes exhibit 
stimulus/response curves that are steeper or less steep than the 
Michaelis-Menten curve. Goldbeter and Koshland have termed 
these responses "ultrasensitivity" and "subsensitivity," respec- 
tively (11-13). An ultrasensitive enzyme requires less than an 
81-fold increase in stimulus to drive it from 10% to 90% maximal 
response (for example, the MAPK and MAPKK curves in Fig. 2); 
a subsensitive enzyme requires more than an 81-fold increase. 
The term ultrasensitivity emphasizes the fact that the upstroke 
of the stimulus/response curve is steeper than that of a hyperbolic 
Michaelis-Menten enzyme, as shown in Fig. 2A. However, 
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FIG. 1. Schematic view of the MAPK cascade. Activation of 
MAPK depends upon the phosphorylation of two conserved sites 
[Thr-183 and Tyr-185 in rat p42 MAPK/Erk2 (4, 5)]. Full activation 
of MAPKK also requires phosphorylation of two sites [Ser-218 and 
Ser-222 in mouse Mek-1/MKK1 (6-10)]. Detailed mechanisms for the 
activation of various MAPKKKs (e.g., Raf-1, B-Raf, Mos) are not yet 
established; here we assume that MAPKKKs are activated and inac- 
tivated by enzymes we denote El and E2. MAPKKK* denotes 
activated MAPKKK. MAPKK-P and MAPKK-PP denote singly and 
doubly phosphorylated MAPKK, respectively. MAPK-P and 
MAPK-PP denote singly and doubly phosphorylated MAPK. P'ase 
denotes phosphatase. 
ultrasensitive enzymes are also relatively less sensitive to small 
stimuli than are Michaelis-Menten enzymes; at low stimulus 
levels their stimulus/response curves are less steep than those of 
Michaelis-Menten enzymes (Fig. 2A). Thus, highly ultrasensitive 
enzymes tend toward all-or-none, switch-like responses. 
The most widely appreciated mechanism for generating 
ultrasensitive responses is cooperativity. Positively cooperative 
enzymes have sigmoidal stimulus/response curves, and require 
less than an 81-fold stimulus to drive them from 10% to 90% 
maximal response. However, cooperativity is not the only 
mechanism through which ultrasensitive responses can be 
generated. Ultrasensitivity also arises when enzyme cycles 
operate near saturation ["zero-order ultrasensitivity" (11)] 
and when stimuli impinge upon multiple steps of an enzyme 
cascade ["multistep ultrasensitivity" (12-14)]. 
We have investigated whether an ultrasensitive, switch-like 
response would be expected of the vertebrate Erkl/Erk2 
MAPK cascade, given what is known about the abundances of 
the members of the cascade and their affinities for each other. 
We solved the rate equations for the cascade numerically, and 
found that the dose/response curves for MAPK and MAPKK 
are predicted to be sigmoidal, with the MAPK curve predicted 
to be as steep as that of a cooperative enzyme with a Hill 
coefficient of nearly 5. We then carried out detailed measure- 
ments of the stimulus/response curves for one MAPKK 
(Mek-1) and one MAPK (p42 MAPK/Erk2) in a highly 
Abbreviations: MAPK, mitogen-activated protein kinase; MAPKK, 
MAPK kinase; MAPKKK, MAPK kinase kinase. 
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Figure 2.3: Mitogen Activated Protein Kinase Cascade. Reprinted with
permission from PNAS: [39] copyright (1996). This model sh ws diagrammatically
the organization of chemical reactions in the MAPK cascade.
long time for MAPK signaling to come to steady state [24].
Consistent with previous studies of the pathway we see that pMEK
(Figure 2.4 ) and ppERK (Figure 2.4B) are activated with increasing doses of
PMA. Furthermore, analyzing the single cell response data (Figure 2.5) we see
that pMEK and ppERK abundance per cell increases smoothly, sharply, and ap-
proximately according to a unimodal log-normal distribution. Quantitatively, the
superiority of the log-normal distribution fit to the data over a normal distribution
is determined by a statistical test and goodness of fit measure (Figure 2.6). Indeed,
application of the Wilcoxon signed-rank test comparing the square residuals from
each of the normal and log-normal distribution fits indicated the residuals were
not equivalent (p = 2.69 x 10−14). In ddition, the sum-square residuals showed
approximately 10 fold preference to the log-normal description.
In summary, for both single cell data sets, gen expr ssion in E. coli and
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Figure 2.4: PMA activation of T cells. The average response of pMEK and
ppE K in T cells activated with PMA. Error bars are standard deviation of the
logarithmic abundance of pMEK and ppERK among individual cells.
phospho-response in T lymphocytes, we found that the distribution of biochem-
ical species were log-normally distributed. In fact, this is a distribution that we
find to be generic in most biological settings studied in the Altan-Bonnet Lab i.e.
when measuring the abundance of surface markers, the secretion of cytokine by
one individual cell, the rate of lymphocyte proliferation etc.
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Figure 2.5: Single cell pMEK and ppERK response to PMA. (A) The
response of ppERK to pMEK in PMA stimulated T lymphocytes. (B-D) Single
cell flow cytometry measurements for the respective PMA dose. The increased
size and shade of blue for a cell represents (pMEK, ppERK) abundances with
higher probability. These figures demonstrate that pMEK and ppERK are acti-
vated unimodally and smoothly, qualitatively maintaining a bivariate log-normal
distribution with increasing doses of PMA.
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Figure 2.6: Fluctuations in MAPK signaling are log-normally distributed.
Demonstration that the logarithmic representation of data is superior to the linear
representation. (A) Bivariate distribution of the linear scale flow cytometry data.
Gaussian distribution fits of the linear scale single cell data projected onto the first
principle component (B) and the second principle component (C). (D) Bivariate
distribution of the logarithmic scale single cell measurements. Gaussian distribu-
tion fits of the logarithmic scale single cell data projected onto the first principle
component (E) and the second principle component (F).
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2.2 Logarithmic chemical Langevin equation
We begin our stochastic treatment of biochemical reactions in single cells by writing
the chemical Master equation as
d
dt
p(n, t) = ΩFp(n− 1, t) + λ(n+ 1)p(n+ 1, t)− (ΩF + λn) p(n, t), (2.1)
where Ω is the volume of the cell, ΩF is independent of n and represents the
probability of producing a single molecule per second, and lastly λ is a constant
in which λn represents the probability of a single molecule degrading per second.
Equation 2.1 represents the temporal evolution of the probability distribution of n
particles observed in time. The goal of our analysis is to compute the magnitude
of the fluctuations in the abundance of each molecular species per cell. As a result
we only need to compute the mean and the variance of our system. With this
in mind, we can approximate the chemical Master equation (Eq 2.1) to a simpler
form that will provide the information we care about.
Consider that the volume of the cell is sufficiently large such that the production
and degradation of individual molecules can be approximated by the continuous
variable x = n
Ω
. Making this change of variables requires that,
p(n, t) =
∫ n+1/2
Ω
x=
n−1/2
Ω
P (x, t)dx, (2.2)
taking r = 1
Ω
and substituting into Equation 2.1 we see that,
∂P (x, t)
∂t
= ΩFP (x− r, t) + Ωλ(x+ r)P (x+ r, t)− Ω(F + λx)P (x, t), (2.3)
our new continuous variable chemical Master equation. Rewriting this equation
with respect to van Kampen’s translation operators [84],
W (x± r, t)P (x± r, t) = e±r∂x [W (x, r)P (x, r)] , (2.4)
29
we arrive at,
∂P (x, t)
∂t
=
[−Ω(F + λx) + e−r∂xΩF + er∂xΩλx]P (x, t). (2.5)
The advantage of this representations is that the entire equation is written in terms
of P (x, t). However, we still haven’t simplified our equation. To do this we expand
Equation 2.5 with respect to r about r = 0,
∂P (x, t)
∂t
=
∞∑
n=1
rn
n!
∂n
∂xn
Ω ((−1)nF + λx)P (x, t), (2.6)
which is the Kramers Moyal Expansion of the Master equation. Indeed, we can
now write an approximate solution of the chemical Master equation by truncating
this series by assuming that r is small. We then truncate the series for n > 2 ≈ 0,
∂P (x, t)
∂t
= − ∂
∂x
[F − λx]P (x, t) + 1
2
∂2
∂x2
1
Ω
[F + λx]P (x, t), (2.7)
which is the Fokker-Planck equation of our system. The advantage of the Fokker-
Planck description is that the chemical Master equation is now transcribed into
a diffusion equation with drift. Consequently, the variance of the corresponding
stochastic process exhibits fluctuations in the abundance of x as 1
Ω
[F + λx] and
the mean dynamics of x according to F −λx. The resulting stochastic process can
then be written as a Langevin equation,
dx
dt
= F − λx+ 1
Ω1/2
√
F + λxξ(t), (2.8)
where ξ(t) is a white noise random variable. We use this equation to describe
the transmission of fluctuations in the abundance of molecules in biological net-
works. Indeed, we consider a set of biomolecular reactions (e.g. gene expression
or phospho-signaling) whose dynamics are described by Equation 2.8, in which
the production rate F is now dependent on the abundance of the interacting
biomolecules,
dxj
dt
=
∑
i 6=j
(fj(xi; θji))− λjxj + 1
Ω1/2
√∑
i 6=j
(fj(xi; θji)) + λjxj ξj(t) (2.9)
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where fj(xi; θji) is the rate of production of biochemical species j controlled by
biochemical species i, θji is the set of parameters that determine the function
fj(xi; θji), and λj is the rate constant for the degradation of species j. The pro-
duction rate fj(xi; θji) is a nonlinear, saturating function representing enzymatic
activity—e.g. the Hill equation. Writing the parameters as quantities that fluctu-
ate around their mean values, λj = 〈λj〉+ δλj, and θji = 〈θji〉+ δθji, we have
dxj
dt
=
∑
i 6=j
(fj(xi; 〈θji〉+ δθji))− (〈λj〉+ δλj)xj
+
1
Ω1/2
√∑
i 6=j
(fj(xi; 〈θji〉+ δθji)) + (〈λj〉+ δλj)xj ξj(t). (2.10)
The inclusion of the parameter fluctuations in the square root terms assumes that
the intrinsic fluctuations ξj(t) are faster than the parameter fluctuations δθji and
δλj. Writing xj as a quantity that fluctuates around its mean value (〈xj〉 + δxj)
we expand Equation 2.10 using the size of the fluctuations as the order parameter,
resulting in terms of order zero (those that do not depend on the fluctuating terms),
those that depend on the fluctuating terms to the first order, and those that depend
on products of two or more fluctuating terms. Disregarding the latter, we obtain
d〈xj〉
dt
+
dδxj
dt
=
∑
i 6=j
(
fj(〈xi〉; 〈θji〉) + ∂fj
∂xi
δxi +
∂fj
∂θji
δθji
)
−
(〈λj〉+ δλj)〈xj〉 − 〈λj〉δxj
+
1
Ω1/2
√∑
i 6=j
(fj(〈xi〉, 〈θji〉)) + 〈λj〉〈xj〉 ξj(t) (2.11)
This equation can be solved hierarchically, order by order. In the stationary state,
the zero-th order terms result in
〈xj〉 = 1〈λj〉
∑
i 6=j
fj(〈xi〉; 〈θji〉) (2.12)
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The first order terms give the equation for the fluctuations in species j
dδxj
dt
=
∑
i 6=j
(
∂fj
∂xi
δxi +
∂fj
∂θji
δθji
)
− 〈λj〉δxj − δλj〈xj〉+ 1
Ω1/2
√
2〈λj〉〈xj〉 ξj(t)
(2.13)
Changing to logarithmic variables, let yj = ln(xj) = ln(〈xj〉 + δxj). Then to the
first order in δxj we have
yj = ln(〈xj〉) + δxj〈xj〉 +O(δx
2
j) (2.14)
and 〈yj〉 = ln(〈xj〉) given that 〈δxj〉 = 0. The logarithmic increment in species j
is
δyj = ln(xj)− ln(〈xj〉) = δxj〈xj〉 (2.15)
Dividing Equation 2.13 by 〈xj〉 we find the equations for the fluctuations in loga-
rithmic scale
dδyj
dt
=
∑
i 6=j
(
〈λj〉∂ ln fj
∂ lnxi
δyi +
〈λj〉
〈θji〉
∂ ln fj
∂ ln θji
δθji
)
− 〈λj〉δyj − δλj +
√
2
〈λj〉
Ω〈xj〉 ξj(t)
(2.16)
Equation 2.16 is the chemical Langevin equation with fluctuating parameters in
log-scale variables linearized about a fixed point at 〈xj〉.
When the abundance of the chemical species represented by Ω〈xj〉 is large, the
fluctuations represented by the last term in Equation 2.16 are small. Formally this
is attained by making the volume Ω tend to infinity. Then, the only remaining
fluctuations in Equation 2.16 are the fluctuations in the parameters, which we
model as Wiener processes (i.e., fluctuations are fast compared with the half life
of the species) ∑
i 6=j
( 〈λj〉
〈θji〉
∂ ln fj
∂ ln θji
δθji
)
− δλj = qjj + qGG (2.17)
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where the ’s are delta-correlated white noise processes. Approximating the left
hand side by the sum of two random variables with constant coefficients is consis-
tent with our experimental observations (discussed further in a proceeding section).
Note that the parameter fluctuations are modeled by one term that is independent
for each species (qjj) and one term that is common to all species (qGG) represent-
ing a global source of parameter fluctuations. Therefore, we have the linearized
system
dδyj
dt
=
∑
i 6=j
(ajiδyi)− 〈λj〉δyj + qjj + qGG (2.18)
where aji = 〈λj〉∂ ln fj(〈xi〉,〈θji〉)∂ ln〈xi〉 . The general form of these equations for arbitrary
regulatory topologies A and normally distributed noise models Q is
d
dt

δy1(t)
...
δyN(t)
 = A

δy1(t)
...
δyN(t)
+ Q

1(t)
...
N(t)
G(t)

(2.19)
where δyi is the logarithmic increment in species i, the entries in the matrix A
are aji as described above for i 6= j and ajj = −λj, and the entries of Q are
independent of the log-concentrations.
In summary, log-scale fluctuations in the concentrations of reacting chemical
species of sufficiently high concentration follow Equation 2.19 therefore the analysis
presented in the main text applies to fluctuations in log-concentration of proteins.
2.3 Tracking the noise
Our premise is that the measured fluctuations of network elements is related to
their connectivity. As a result the covariances and variances of measured observ-
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ables among an ensemble of clonal single cells is reflective of the their interconnec-
tivity. In order to determine the functional relationships between the measured
observable covariances, we analyze a linear stochastic dynamical system where each
species is represented by the stochastic differential equation
d
dt
yj(t) =
N∑
i=1
ajiyi(t) + qjiξi(t). (2.20)
Here yj(t) represents the logarithmic fluctuations of biochemical species j from its
mean abundance (for reading convenience we replace δyj from the previous section
with yj), aji is the rate of change of species j in response to the presence of species
i, qji is the contribution of the i
th species intrinsic noise to the jth species intrinsic
noise, and ξj(t) is a white noise random variable. The white noise is characterized
by two observations
〈ξj(t)〉 = 0 and
〈ξj(t)ξi(t+ τ)〉 = δjiδ(τ),
where δji is the Kronecker delta function and δ(τ) is the Dirac delta function.
The entire system of equations can be compactly written as
d
dt
y = Ay + Qξ(t), (2.21)
where the matrix A (dimension N x N) contains all of the network connectivity
information and Q is an N x M matrix representing the magnitude of M noise
sources to the N biochemical reactions. Note, that for theoretically ideal systems
where the fluctuations in the dynamics are exclusively attributable to the reactions
of each chemical species, Q would be an N x N diagonal matrix. Finally, y is an N
dimensional column vector representing the fluctuations of each biochemical species
and ξ(t) is an M dimensional random white noise random variable. We proceed
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by computing the correlation functions associated with the presented stochastic
dynamical system.
The solution of the stochastic dynamical systems can be written as
y(t) =
∫ t
s=−∞
eA(t−s)Qξ(s)ds. (2.22)
Here we see that the network connectivity described in A and the noise matrix
Q determine the propagation of noise throughout the network. To obtain an
explicit relationship between covariates, we compute the pairwise correlation func-
tions between biochemical species. The pairwise correlation function takes the
form
Σ(τ) =
〈
y(t)yT (t+ τ)
〉
, (2.23)
=
∫ t+τ
s′=−∞
∫ t
s=−∞
eA(t−s)Q
〈
ξ(s)ξ(s′)T
〉
QT eA
T (t+τ−s′)dsds′. (2.24)
Application of the properties of the white noise random variables ξ(t),
Σ(τ) =
∫ t
s=−∞
eA(t−s)QQT eA
T (t−s)ds︸ ︷︷ ︸
Σo
eA
T τ , resulting in (2.25)
Σ(τ) = Σoe
AT τ , (2.26)
where Σo is the unlagged covariance matrix (independent of τ), and e
AT τ represents
the memory of the system to the random perturbations by ξ. In motivating the
problem statement, we indicated that the average dynamics of our system is at
steady state. We continue with the conjecture that the correlation function is also
at steady state - a condition of stochastic processes referred to as weakly stationary.
Invoking this condition by setting the time derivative of the correlation function
to zero we see that
d
dt
Σ(τ) = 0, (2.27)
AΣ(τ) + Σ(τ)AT = −QQT eAT τ (2.28)
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Ideally, our task at this point would be complete. We have obtained explicit rela-
tionships between the network connectivity A, noise matrix Q, and the measurable
correlation matrix Σ. However, this representation requires measurements from a
single cell sampled at a time interval much shorter than the reaction network cor-
relation timescale. With this type of data, the temporal auto and cross correlation
functions can be computed and compared to the theoretical predictions given the
network connectivity and noise matrix Q. However, our single cell measurements
preclude any repeat measurements of the abundance of the biochemical species
from the same cell.
We proceed by invoking the assumption of ergodicity - the equivalence of the
ensemble statistics to the statistics of an individual entity measured for all time.
While seemingly extreme, we have no reason to not assume ergodicity. The cells
whose response we measure are clonal, grown identically, and perturbed in a well
mixed homogeneous environment. Therefore, we continue with only the description
of the measurable unlagged, τ = 0, covariance written as
AΣo + ΣoA
T = −QQT . (2.29)
Equation 2.29 is as a Lyapunov equation. The equation is used in dynamical
systems to find network connectivities that result in stable dynamic solutions [51].
In contrast, in our system the existence of a stable solution is not in question,
we exclude systems that are feedback regulated from this analysis. However, we
are interested in how the network connectivity manifest into unique functional
relationships between covariance elements, a topic we explore further in the next
section.
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2.4 Functional relationships between covariance elements
The key insight from the previous section is that the covariance matrix changes in
a theoretically predictable way (specified by Equation 2.29) in response to exter-
nal perturbations. The perturbations modulate the connectivity strengths between
pairs of interacting components according to the physical constraints of the system
studied. While the subsequent analysis is general and applicable to any dynamical
system treated by linear Langevin equations, we focus specifically on the applica-
tion to our biochemical systems (Eq 2.19).
We chose to describe the biological reactions in cellular signaling networks
as a hill equation. The hill equation is a nonlinear function that describes the
production of a biochemical product j in response to the abundance of biochemical
species i, written as
fji(xi; θji) = νji
x
nji
i
x
nji
i + κ
nji
ji
for θji = [νji, nji, κji], (2.30)
where xi is the abundance of the biochemical species i. nji determines whether
the biochemical reaction is inhibitory or activating, and controls the steepness of
the interaction. Examining the possible values of nji we see that
nji

> 0 for activating interactions,
< 0 for inhibiting interactions,
= 0 for no interactions.
The parameter νji represents the amplitude of the response, and κji represents the
half effective abundance of i required to change the abundance of j by 50% of its
maximal response. We chose this model for the following reasons: the resulting
sigmoidal behavior of this function represents a good approximation to the behavior
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of enzymatic reactions, and it is transparent - it is easy to ascertain the behavior
of the function to changes in variables and parameters.
As a result of the nonlinear functional form of the Hill equation, we approximate
the connectivity strengths, aji, to first order with respect to the logarithmic changes
in xi (Eqs 2.15,2.16,2.18),
aji = 〈λ〉 kji = 〈λ〉 ∂ ln fji
∂ lnxi
∣∣∣∣
xi=ln(〈xi〉)
, (2.31)
in accordance with the linear Langevin systems theory.
In the subsequent sections we apply our Lyapunov equation (Eq 2.29) to mea-
sure the propagation of protein abundance fluctuations for both simulated and
experimental data. Our simulated data are used to examine the unique propaga-
tion of fluctuations through signaling networks with different connectivities. We
use our Lyapunov equation (Eq 2.29) to derive functional relationships between
covariance elements with respect to the network configuration A. We then proceed
by applying our analysis to experimentally measured covariance elements, and at-
tempt to extract information about the connectivity of the measured components.
This analysis is performed in two experimental systems: 1) a synthetic E. coli gene
regulatory system in which the data were collected and previously published by
Pedraza and van Oudenaarden [64] and 2) MAPK phospho-signaling in primary T
lymphocytes.
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2.4.1 Noise propagation in the linear two node network
Consider a network composed of a single directional edge spanning two compo-
nents, y1 and y2 (Figure 2.7A), and a diagonal noise matrix,
d
dt
y1
y2
 =
−λ 0
a21 −λ

︸ ︷︷ ︸
A
y1
y2
+
q1 0
0 q2

︸ ︷︷ ︸
Q
ξ1(t)
ξ2(t)
 . (2.32)
Where, λ is the rate characterizing the decay of each components abundance,
and a21 represents the strength of the interaction between biochemical species 1
and 2 as defined Equation 2.31. The corresponding solution to the Lyapunov
equation (Eq 2.29) for the covariance elements with respect to A and Q provides
our desired description of the transmitted fluctuations. The resulting covariance
matrix elements are:
σ21 = α, (2.33a)
σ12 =
αa21
2λ
, and (2.33b)
σ22 = β +
αa221
2λ2
; (2.33c)
where α =
q21
2λ
and β =
q22
2λ
represent the contribution of the intrinsic fluctuations
to the respective variances.
By examining the expressions representing the variances of y1 and y2, we clearly
see the unidirectional transmission of fluctuations from the the first component (y1)
to the second component (y2). Indeed, the variance of y1 is exclusively dependent
on the intrinsic biological fluctuations, α. In contrast, the variance of y2 depends
on both its intrinsic biological fluctuations β and the those transmitted from the
first component α. The extent that fluctuations are propagated from the first
to the second component is tuned by the connectivity strength, the stronger the
connection the higher the propagation.
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Indeed, experimental tools to modify the connectivity strength are often limited
to exogenously administrated activating signal. Analogously, we performed an in
silico dose response and examined the connectivity strength for changes in ln(〈x1〉),
represented by y˜1, abundance. We see that a21 non-monotonically changes with
the increasing abundance of y˜1 - first a21 increases, reaches a maximum, and then
decays (Figures 2.7B,C), an obvious consequence to taking the derivative of a
sigmoidal function. We then examined how the fluctuations from y1 propagate to
y2 by evaluating σ
2
2 (Equation 2.33) for each dose of activating signal.
Instead of explicitly evaluating the dependence of σ22 with respect to a21 -
a quantity often difficult to experimentally measure - we propose an alternative
approach that complements our single cell experiments. Our approach is to rely
upon the theoretical proportionality of covariance elements between y1 and y2 and
the connectivity strengths. By reexamining our solutions in Equations 2.33 with
respect to the variances of y1 and y2 and the covariance σ12 instead of a21, we see
that
σ21 = α, and (2.34a)
σ22 = β + 2
σ212
α
. (2.34b)
The theory now emphasizes that noise propagates in the system as the quadratic
of the covariance between interacting components. In accordance with these equa-
tions, our in silico experiments recover the invariance of σ21 to σ12 (Figure 2.7D),
and the quadratic dependence of σ22 on σ12 (Figures 2.7E). Here, we have theo-
retically demonstrated how the functional relationships of two very simple exper-
imental measurements can track the fluctuations from one biochemical species to
another.
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Figure 2.7: Propagation of fluctuations in the two node system. (A) Di-
agram of the simple two node network. (B) The response of ln 〈x2〉 = y˜2 with
respect to changes of ln 〈x1〉 = y˜1. The color map from blue to red indexes the
stimulation strength. (B) Changes in the connectivity strength in response to our
in silico titration experiments. (C) The corresponding response of the the variance
of y1 with respect to the covariance of y2. (D) The quadratic dependence of the
variance of y2 with respect to the covariance σ12.
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2.4.2 Noise propagation in the fan-in network
Next we investigated the functional relationships of covariance elements of the fan-
in network. In the fan-in network, component two (y2) is regulated by components
one (y1) and three (y3, Figure 2.8A), and is described by the following dynamical
system,
d
dt

y1
y2
y3
 =

−λ 0 0
a21 −λ a23
0 0 −λ

︸ ︷︷ ︸
A

y1
y2
y3
+

q1 0 0
0 q2 0
0 0 q3

︸ ︷︷ ︸
Q

ξ1
ξ2
ξ3
 . (2.35)
Solving for the covariance matrix elements according to the Lyapunov equation,
(Equation 2.29) the network connectivity, A and noise Q yields:
σ21 = α, (2.36a)
σ23 = γ, (2.36b)
σ12 =
αa21
2λ
, (2.36c)
σ13 = 0, (2.36d)
σ23 =
γa23
2λ
, and (2.36e)
σ22 = β + 2
σ212
α
+ 2
σ223
γ
, (2.36f)
where α =
q21
2λ
, β =
q22
2λ
, and γ =
q23
2λ
. As a result of y1 and y3 being independently
regulated by the signal, the fluctuations from each respective source contributes
independently to the variance of y2 (Equation 2.36f). Consequently, the covariance
elements in the fan in network may exhibit functional relationships that deviate
from the ideal linear two node system (Figure 2.7E, 2.8E). The extent of the
deviation depends on the parameterization of the model.
Figure 2.8, for example, is parameterized such that the in silico activation of
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the network results in a (σ12,σ
2
2) cycle or loop. The loop is a manifestation of the
staggered activity of component two with respect to the activity of components one
and three (Figure 2.8). Indeed, the specific parameters are such that the sensitivity
κ23 < κ21 results in a23 reaching a higher maximum and at lower abundance of y˜3
than that of a21 (Figure 2.8C). The activity of component one is only dependent
on the stimulus strength and its intrinsic biological fluctuations, which results in
a σ21 invariant to σ12 (Figure 2.8D). Meanwhile, the staggered connectivities of
component one and three contribute to the fluctuations of σ22 for different stimulus
activity. The loop is a combined result of the staggered connectivities of the
upstream components.
The staggered connectivity strengths determine the order in which (σ12,σ
2
2)
ordered pairs change with respect to increases of stimulation strength. Consider
the following table (Table 2.1) that separates the stimulus activity into three simple
regimes. When the stimulation strength is low, the effective network is composed of
Table 2.1: Analysis of the fan in network. Analyzing the system of equations
in three simple regimes: low, medium, and high stimulating conditions emphasizes
how fluctuations are transmitted through the network.
Stimulation Strength Connectivity Strength Covariance Effective network
low a21 < a2,3 σ12 < σ2,3 y3 → y2
medium a21 = a2,3 σ12 = σ2,3 y3, y1 → y2
high a21 > a2,3 σ12 > σ2,3 y1 → y2
only component three activating component two. The (σ12,σ
2
2) plane represents this
as in an increase of σ22 but not σ12. Increasing the stimulation strength to medium
will results in equal contributions of both components, where a21 crosses a23 in
Figure 2.8C, leading to an increase in both the σ12 and σ
2
2. Lastly, by increasing
the stimulation to high results in the effective network of component one activating
component two. The corresponding behavior in the (σ12,σ
2
2) plane converges to the
isolated two component quadratic dependence first shown in Figure 2.7E. This is
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obvious from the model equations in the high dose regime; σ23 ∝ a23 → 0 (Eq 2.36e)
resulting in the simplification of Equation 2.36f into the two node model expression
(Eq 2.34b). The overall result is a loop pattern shown in Figure 2.8E.
An attractive feature of tracking the noise in biochemical networks is the char-
acterization of unmeasured components. Indeed, the presence of a cycle in the
covariance and variance plane is informative of unmeasured quantities, however
the converse is not true. The absence of a loop does not eliminate the possi-
bility of unmeasured biochemical interactions. For example if a21 = a23 for all
doses, the data projected onto the covariance and variance plane would exhibit
the two component quadratic behavior. Although, this limitation is restricted to
semi-quantitative functional relationships discussed so far, it does not preclude the
ability to infer unmeasured interactions from detailed quantitative assessments.
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Figure 2.8: Propagation of fluctuations in the fan in system. (A) Diagram
of the fan in network structure. (B) The responses of y˜2 with respect to y˜1 and
y˜3 exclusively, as before activating signal increases from blue to red. (C) The
connectivity strengths of y2 corresponding to either y1 or y3. (D) The variance of
y1 remains invariant to σ12. (E) The (σ12,σ
2
2) plane shows a signature of fluctuations
of y2 transmitted by both y1 and y3.
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2.4.3 Noise propagation in a cascade network
Lastly, we consider the cascade network, in which a stimulus activates compo-
nent three, which activates component one, followed by component one activating
component two. The dynamics of this network are described by
d
dt

y1
y2
y3
 =

−λ 0 a13
a21 −λ 0
0 0 −λ

︸ ︷︷ ︸
A

y1
y2
y3
+

q1 0 0
0 q2 0
0 0 q3

︸ ︷︷ ︸
Q

ξ1
ξ2
ξ3
 . (2.37)
Solving for the covariance elements in Equation 2.29 with respect to the cascade
network yields:
σ23 = γ, (2.38a)
σ13 =
γa13
2λ
, (2.38b)
σ21 = α + 2
σ213
γ
, (2.38c)
σ23 =
γa21a13
4λ2
, (2.38d)
σ12 =
αa21
2λ
+
3γa21a
2
13
8λ3
, and (2.38e)
σ22 = β + 2
γσ212
αγ + 3σ213
, (2.38f)
where α =
q21
2λ
, β =
q22
2λ
, and γ =
q23
2λ
. In this network the fluctuations of compo-
nent one are now dependent on the stimulation strength by the connectivity a13
(Eq 2.38c). In addition, the measured σ12 is no longer a representation of compo-
nent one and two exclusively, but depends also on the connectivity a13. As a result,
both σ12 and σ
2
1 are functionally dependent on the connectivity a13 which manifests
as a loop in the (σ12,σ
2
1) plane (Figure 2.9D, we will explore alternative parame-
terizations later). Meanwhile the description of σ22 is complex for two reasons: 1)
σ12 is dependent on two connectivities, and 2) the propagation of fluctuations are
46
dependent on the quotient of σ12 and σ13. Indeed, the cascade network is easily
identifiable by the presence of loops for both covariance and variance planes in
Figures 2.9D,E, however the precise shape of the possible (σ12,σ
2
2) representations
are diverse (Figure 2.10).
We next investigated the sensitivity of our covariance and variance represen-
tation to the model parameters of the cascade network. Figure 2.10 shows our
systematic change in the model parameters. Each row of Figure 2.10 corresponds
to increases in both the maximum connectivity strength and the sensitivity of a21
(Figure 2.10B,F,J,N, column aji(y˜3)). The sensitivity of aji represents the abun-
dance of y˜3 in which aji is maximum. From this analysis two features become ap-
parent. First, the simulated data shows that the size of loops in the covariance and
variance representations are dependent on the relative sensitivities. When the sen-
sitivities of the aji’s are equivalent, we see the complete elimination of loops in the
covariance and variance planes (Figures 2.10K,L). In contrast, the size of the loops
increased with the increase separation of the connectivity sensitivities (Fig 2.10,
columns σ1(σ12) and σ2(σ12)). Secondly, we see that the relative sensitives of aji’s
determine the order in which the increasing stimulation strengths change the re-
spective covariances and variances. For example, consider Figure 2.10C and G,
here the sensitivity of a13 is greater than a21 and results in an increase of σ
2
1 with-
out a corresponding increase in σ12. Indeed this result is a general feature of our
covariance and variance representation. Increases of variance elements without
the corresponding change in the covariance occurs when the covariance does not
account for the fluctuations propagated to the measured variance, e.g. the system
is more sensitive to an unmeasured quantity. Indeed, the opposite is true when
the connectivity between measured pairs (y1,y2) is more sensitive than the con-
tribution from the third unmeasured component (Figure 2.10O). In this example
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Figure 2.9: Propagation of fluctuations through the cascade network. (A)
Diagram of the cascade network structure. (B) The responses of y˜1 and y˜2 to
changes in y˜3, for increasing stimulus strength (blue→ red). (C) The connectivity
strengths a21 and a13 representing each pair of biochemical reactions. (D) The
covariance and variance plane of y1. (E) The covariance and variance plane for y2.
48
we first see a concomitant increase of both σ12 and σ
2
2, because the fluctuations
of y2 are accounted for by the covariance. As the stimulation strength increases
the fluctuations from the unmeasured component increase while the measured de-
crease. As a result σ22 increases despite the reduction in the measured σ12. Taken
together the propagation of fluctuations are highly dependent to the connectivity
of the network.
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Figure 2.10: Parameter sensitivity in the cascade network. (A) The loga-
rithmic responses of component one and two with increasing component three. (B)
The connectivity strength for each value of y˜3. (C) Characterization of the propa-
gation of fluctuations measured in the (σ12,σ
2
1) plane. (D) Characterization of the
propagation of fluctuations measured in the (σ12,σ
2
2) plane. The model presented
in (A-D) is identical to that of Figure2.9, we include these graphs to facilitate
comparisons to changes in model parameterization. (E-P) Each row represents the
identical column-wise analysis of (A-D) but with unique parameterization of the
model functions. The parameters change such that the amplitude of the maximum
connectivity strength a21 and the sensitivity of a21 to y˜3 increase. The sensitivity
of a21 is the abundance of y3 such that a21 is at maximum strength.
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2.5 Noise propagation in single cells
To see if our analysis captures the properties of noise propagation in living systems
we tested our theory on two known signaling systems. First, on published data of
gene activity in a synthetic negative regulatory system expressed in E. coli [64].
Secondly, in Mitogen Activated Protein Kinase (MAPK) phospho-signaling in T
lymphocytes. Each experimental model system consisted of single cell measure-
ments that concomitantly quantified the abundance of each interacting biochemical
species. We then estimated the covariance elements from the ensemble of single
cell measurements for different doses of exogenously administered stimuli. With
these data we were able test our the functional relationship of covariance elements
in the isolated two component model.
Application of our theoretical predictions required that we account for experi-
mental limitations. For each study we measured fluorescent markers that correlated
with the abundance of our molecule of interest. However, these measurements are
prone to additional noise introduced by the autofluorescence of cells, and / or non-
specific binding of fluorescent molecules. We accommodated for these sources of
noise with the extra terms (qg, ξg) resulting in
d
dt
 y1
y2
 =
 −λ 0
a21 −λ

 y1
y2
+
 q1 0 qg
0 q2 qg


ξ1
ξ2
ξg
 , (2.39)
dynamic equations. We then solved for the covariance elements using our derived
Lyapunov equation (Eq 2.29), which yielded,
σ21 = α + ηg and (2.40a)
σ22 = β + ηg
(
1− 2σ12
σ21
)
+ 2
σ212
σ21
. (2.40b)
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If we take ηg → 0, we return to our theoretical results of the isolated two compo-
nent system (Eq 2.34).
Lastly, we demonstrate how our model of the covariance elements facilitates
the inference to the direction of the biochemical reactions. Equation 2.39 supposes
that the abundance of y2 changes in accordance to the dynamics of y1. However,
we could have easily built the opposite model. We can test which of these models
represent the ‘true’ model by comparing the residuals between the fit of each model
and our data. The estimated parameters θˆm of model m were numerically found by
minimizing the sum square residuals. The model with consistently smaller errors
represents the most likely direction of the biochemical interaction. We statisti-
cally evaluated the best description of the data by performing two statistical tests.
First, we used a two-sided non-parametric Wilcoxon singed rank test, whose null
hypothesis is that the difference of paired residuals from each model are sampled
according to a symmetric distribution around zero. Indeed, a rejection of this
hypothesis indicates that one model out performs the other. If the data are suf-
ficiently different we proceed by using a one-sided Wilcoxon signed-rank test to
obtain a p-value representing our certainty of the best model.
2.5.1 Tracking fluctuations in an E. coli gene regulatory
network
We analyzed the published data from Pedraza and van Oudenaarden [64] to test
our noise propagation methodology. The experiment consisted of exogenous doses
of IPTG and single cell measurements of steady state abundance of CFP (G1) and
YFP (G2). By increasing the dose of IPTG they were able to strengthen the induc-
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tion of g1 (Figure 2.1) and consequently reduce the expression of g2 (Figure 2.1).
The concomitant measurements of G1 and G2 per cell allows us to correlate the
average response of G2 with respect to G1 (Figure 2.1C). We see that the average
response is well approximated by the hill equation (Eq 2.30), with n < 0 represent-
ing the inhibitory interaction. We next tested our covariance and variance analysis
in characterizing the propagation of noise from G1to G2.
Figure 2.11D shows our estimation of covariance elements and the resulting
isolated linear two component prediction. From our analysis we see two impor-
tant features in our data. First, our estimation of σG1,G2 is negative for IPTG
doses in the dynamic range of the average G1 and G2 response. Indeed this re-
sult complements our developed theory, which states that the covariance between
two elements is proportional to the connectivity strength (Eq 2.33b). We charac-
terized the connectivity strength by the logarithmic gradient of the hill equation
(Eq 2.31). The maximum absolute value of the log-gradient corresponds to the
position of G1 with induces the greatest response in G2. Furthermore, the sign of
the covariance originates from n < 0 and is indicative of the inhibitory interaction
(Figure 2.11C). Secondly, the variance corresponding to both genes qualitatively
behaves in accordance with our predictions. Namely, that σ2G1 is invariant to the
measured covariance, while σ2G2 increases roughly by the square of the covariance
(Fig 2.11D). Our model and the corresponding data captures our intuition, that
noise propagates unidirectionally in biochemical reactions, however the deviation
between the measured G2 variance and model requires closer attention.
The dispersion of G2’s variance with respect to the isolated two node model is
likely a consequence that the regulatory circuit is best represented as a cascade,
and not our simplified two node model. Recall that G1 is activated by G0, and
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that the dosage of IPTG inhibits G0’s negative regulation of G1. Indeed, our
analysis of the cascade network (Figure 2.10) showed how fluctuations from G0
could have small influences to the measured variance of G1 and generate a small
loop for the variance of G2. We did not pursue incorporating the more complex
model to our data. This is because, the number of model parameters with this
additional component increases our current number of parameters from two to five,
and would likely be over-fitting our data. The over-fitting could be circumvented by
measurements of active G0 in addition to G1 and G2, however these measurements
are not available.
We conclude our analysis of the E. coli gene data by applying our directionality
test. Figure 2.12 shows the optimal fit of the isolated two node model for both
network directions. Indeed, the true direction of the biochemical interaction is eas-
ily determined by inspection, and confirmed by our prescribed statistical analysis,
p = 1.2 x 10−7 for N = 23 data points representing each IPTG dose.
In summary our theoretical description of the properties of noise propagation
is in agreement with the data from the synthetic gene regulatory network first
studied by Pedraza and van Oudenaarden [64].
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Figure 2.11: Noise propagation in an E. coli gene regulatory network (A)
The logarithmic change of G1 expression with increasing exogenous doses of IPTG.
(B) The logarithmic change of G2 expression with increasing exogenous doses of
IPTG. Error bars in (A-B) represent the standard deviation of the respective gene
expression among cells. (C) The average response of G2 to changes in G1. (D) The
measured (σG1,G2 ,σ
2
i ) for i = {G1,G2} of single cell gene expression for various
doses of IPTG. Error bars are ± one standard deviation computed from 1000
bootstraps. The respective lines for G1 and G2 represent the best fit of our model
(Eq 2.40) from the linear two node configuration.
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Figure 2.12: Gene regulation directionality test The covariance and variance
plots with competing model fits. The true model represents a fit of covariance
elements for the designed interaction, G1 → G2. In contrast the false model fits
the covariance elements according to the interaction G2 → G1.
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2.5.2 Tracking fluctuations in MAPK signaling of PMA
activated T lymphocytes
We extended our theoretical description of noise propagation in biochemical sys-
tems to phospho-signaling in T lymphocytes. We measured the transmission of
phosphates among two members of the Mitogen Activated Protein Kinase Cas-
cade, namely phosphorylated MEK (pS221) and doubly phosphorylated ERK
(pT202,pY204) by flow cytometry. To activate this signal transduction cascade
and modulate the connectivity strengths between these pMEK and ppERK, we
treated the cells with various doses of PMA, a potent activator of the MAPK
pathway (Figures 2.13A,B). As before with the E. coli data, the concomitant
measurements of pMEK and ppERK allow us to correlate the average response
of ppERK to pMEK. These data were well approximated by the Hill equation
(Eq 2.30) with n > 0. We next tested the ability of our theoretical description of
the isolated two node system in describing the transmission of fluctuations from
pMEK to ppERK.
Figure 2.13D shows our estimations of the covariance elements for each adminis-
tered dose of PMA (Eq 2.40). The covariance measurements are all positive, which
is in accordance to the known biology and the positive correlation in Figure 2.13C,
indeed pMEK increases the abundance ppERK. In addition, measurements of the
variance indicate that ppERK is downstream of pMEK - we show that the variance
of ppERK increases with covariance of pMEK and ppERK, while pMEK remains
invariant. Again, this is consistent with the well established biochemistry of the
MAPK pathway. Most interestingly, and similar to the E. coli analysis, we see
that our measurements of the σ2ppERK minimally deviate from the ideal isolated
two node model. Indeed, the MAPK signaling pathway is a series of activation
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reactions and thus may be best represented by the cascade network. Our results
show that the biochemical parameters of this pathway are set to mimic the isolated
two component system [82].
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Figure 2.13: Noise propagation in MAPK signaling in T lymphocytes.
(A) The logarithmic change in abundance of phosphorylated MEK (pS221)
with increasing exogenous doses of PMA. (B) The logarithmic change in abun-
dance of phosphorylated ERK (pT202,pY204) with increasing exogenous doses
of PMA. (C) The increase of ppERK with increasing pMEK. (D) The measured
(σpMEK,ppERK, σ
2
i ) for i = {pMEK,ppERK} of single cell phospho-signal for vari-
ous doses of PMA. Error bars are ± one standard deviation computed from 1000
bootstraps. The respective lines for pMEK and ppERK represent the best fit of
our model (Eq 2.40) from the linear two component configuration.
We conclude our analysis of noise propagation in MAPK signaling of T lympho-
cytes by applying our directionality test. Indeed, inspection of Figure 2.14 shows
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that application of the true model, pMEK → ppERK, best represents the trans-
mission of noise. We statistically quantified this result by the previous described
prescription and obtain p = 1.5 x 10−5 for N = 24.
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Figure 2.14: Phospho-signaling directionality test The covariance and vari-
ance plots with competing model fits. The true model represents a fit of covariance
elements for the canonical signaling pathway, pMEK → ppERK. In contrast, the
false model fits the covariance elements according to the interaction, ppERK →
pMEK.
2.5.3 Constant magnitude of intrinsic noise, an experimen-
tal evaluation
We extend the results from the previous section to assess the validity of a key
assumption in our model. In our derivation of the logarithmic chemical Langevin
equation, we assumed that the sum of the fluctuations originating from physico-
chemical laws of chemical reactions and the fluctuations of parameters are con-
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Figure 2.15: Global noise estimate The global noise was fit by minimizing the
sum-square residuals of the data in the new coordinates (Eq 2.41). The data
exhibited a correlation coefficient of 0.76.
stant (Eq 2.17). We checked this assumption by using a simple rearrangement of
Eq 2.40b, resulting in
σ2ppERK,i − 2
σ2pMEK,ppERK,i
σ2pMEK,i︸ ︷︷ ︸
Yi
= β + ηg
(
1− 2σpMEK,ppERK,i
σ2pMEK,i
)
︸ ︷︷ ︸
Xi
, (2.41)
a straight line with respect to the new coordinates (X, Y ). Rewriting, we see that
Yi = β + ηgXi, (2.42)
in which ηg represents the slope and β the Y intercept. We estimated these pa-
rameters by minimizing the sum-squared residuals (Figure 2.15). Substituting our
estimated global noise, ηˆg, into a rearrange expression of Equation 2.40b,
βi = σ
2
ppERK,i − ηˆg
(
1− 2σpMEK,ppERK,i
σ2pMEK,i
)
− 2σ
2
pMEK,ppERK,i
σ2pMEK,i
, (2.43)
allows us to estimate βi for each data point. This may seem counter-intuitive, in
that we just estimated βˆ from our linear model (Eq 2.41). True, however, the
estimated βˆ from the linear fit represents an average over all samples, and our goal
is to assess any systematic changes of βi across the various stimulating conditions.
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Figure 2.16 shows the resulting βi for different ppERK activity strengths. Indeed,
βi exhibits a negligible dependency with ppERK activation strength - a linear fit
of the data results in a slope of -0.03. These results suggest that our assumption
of constant Q is representative of the intrinsic biological fluctuations of ppERK in
our experimental settings.
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Figure 2.16: Experimental confirmation of constant intrinsic biochemical
fluctuations. The measured variance (blue) and intrinsic biochemical fluctuations
(β,black) of ppERK in T lymphocytes. Line is a linear fit of with respect to the
mean activation of ppERK.
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2.5.4 Identifying systems with stimulus dependent intrin-
sic noise
Our analysis of noise propagation is predicated on the experimentally vetted as-
sumption that Q is invariant to stimulation. Indeed, such a constraint is most
likely not appropriate for all biological systems. As a result we aimed at character-
izing a clear diagnostic criteria to easily identify systems in which the magnitude
of the noise is dependent on the stimulation strength. We limit ourselves to the
isolated two component model (Eq 2.40b) and sources of noise that increase in
magnitude with stimulation strength.
Let’s consider this system exposed to two extreme stimulatory conditions,
namely smin and smax, such that σ12 → 0 at both locations. In Figure 2.17A
we see the desired behavior, the network connectivity, and the corresponding co-
variance, for the extreme values of y1 do indeed approach zero. By comparing the
variances of y2 for each condition results in
σ22(smax)− σ22(smin) = β(smax) + ηg(smax)− β(smin)− ηg(smin). (2.44)
If β and ηg are constant as in our analysis, then the resulting difference is zero
(Figure 2.17B). However, if β and ηg were to increase with stimulation as assumed,
then the end points would not meet as depicted by Figure 2.17C. As a result, visual
inspection of the covariance and variance plane is sufficient for identifying systems
in which our constant noise constraint is not suitable.
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A B C
Figure 2.17: Signatures of extrinsic noise (A) The response of y2 with changes
of y1 from the isolated two component model. (B) Covariance and variance plane
representation of the noise propagation according to Equation 2.40b. (C) Covari-
ance and variance plane in the isolated two node network with dose dependent
fluctuations.
2.6 Summary
We experimentally uncovered that fluctuations in the abundance of biochemical
species propagates according to a system of logarithmic biochemical Langevin
equations. Using these equations we derived a Lyapunov equation, and as a result
uncover a connection between the network connectivity A, the estimated covari-
ance matrix from single cell measurements Σ, and the intrinsic noise matrix Q.
Using this method, we theoretically assessed the propagation of fluctuations in
three biologically inspired networks: linear two node, fan-in, and a cascade. These
findings were experimentally validated in a synthetic IPTG controlled E. coli gene
regulatory network [64], and PMA activated MAPK phospho-signaling in primary
mouse T lymphocytes. By leveraging the properties of noise propagation it is
possible to infer the directionality of biochemical reactions from single cell data
recorded at a single point in time, and measure signal originating from unmeasured
signaling components. Together, we have provided a powerful tool that is built
upon simple and robust calculations to study biochemical networks in living cells.
63
CHAPTER 3
SINGLE CELL MEASUREMENTS FOR MECHANISTIC
CHARACTERIZATION OF SMALL MOLECULE CHEMICAL
INHIBITORS
Individual cells rely on biochemical signaling pathways to translate environ-
mental cues into physiological responses. Spurious activation of these pathways
result in a cell’s mischaracterization of environmental conditions and aberrant cel-
lular behavior. This behavior can, in some cases, be detrimental to the health
of the organism - causing ailments such as inflammatory diseases (e.g. ulcerative
colitis [71]), auto-immune disorders [85, 60] and cancer [37]. A promising strategy
in battling these diseases is the application of specific small molecule chemical in-
hibitors that target the dysregulated signaling element(s) and thereby rectify cellu-
lar behavior [56]. However, despite the tremendous success of few small-molecule
therapies such as Imatinib in treating Chronic Myelogenous Leukemia [43] and
Gefitnib for patients with EGFR mutant non small cell lung cancer [61, 53], the
rate of success in drug development has remained incredibly slow and the field of
pharmacology may need new tools to help in the development and screening of
candidate compounds in more relevant settings [46, 88].
The process of drug development is organized at different levels of increasing
biological scales: biomolecular, cellular, animal and lastly humans. Recent tech-
nological advances have established a pipeline to characterize in vitro and at the
molecular level the specificity of one drug with respect to the entire human ki-
nome [29, 45, 25]. Problems abound when attempting to expand this molecular
understanding to the cellular scales. Indeed, there exist technologies such as ki-
nobeads, that were developed to measure drug specificity and to assess response of
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signaling networks to inhibition of kinases in cell lysates e.g. by quantitative mass
spectrometry [8]. However, advances screening technologies at the single cell scale
diverge from mechanistic understanding - focusing on automated characterization
of cellular ‘systems’ responses [65] and behavior of phenomenologically defined
populations in cell lines [75]. Yet, despite these technological advancements there
still remain too many poorly performing compounds proceeding to the organismal
stage of drug discovery - forcing us to re-evaluate the relevance of cell line model
systems and the need for mechanistic detail in studying single cell responses (Whats
wrong with drug screening today, [59]). In response, pioneering studies of primary
cells using multidimensional single cell technologies, e.g. Flow Cytometry and Cy-
tometry Time of Flight (CyToF) measurements, have characterized biochemical
networks [40, 69] and canonical cell types response to inhibition[49, 12, 14]. While
these studies have been illuminating, mechanistic principles of cellular responses
to small molecule chemical inhibition has remained elusive.
Indeed the mechanistic description of response to external perturbations at the
individual cell level remains an active field of investigation of practical and funda-
mental significance. Notably, single cell analysis of early T lymphocyte activation
events showed how the biochemical organization of the T cell receptor signaling
pathway can assess the quality and quantity of peptide presented [4, 32]. The
mechanistic details of the proposed model led to the theoretical prediction and
experimental validation of the fact that the endogenous variability of protein is
sufficient to diversify individual cell responsiveness to antigen [31]. Similarly, Co-
tari and Voisinne et al [22] introduced a new methodology, Cell to Cell Variability
Analysis (CCVA), to show how the diversity of IL2 Receptor α tunes the sensi-
tivity of the individual T cell response to IL-2. A finding that has implications
for the differentiation of T cells to either effector or memory phenotype during
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an immune response [41]. Other examples where the study of cell-to-cell variabil-
ity led to functional insight, pertain to many different biological phenomena. For
example,variable abundance of the surface receptor Sca-1 in hematopoietic pro-
genitor cells was shown to correlate with biased differentiation into erythroid or
myeloid lineages [17]; diversity in the intracellular levels of phosphorylated ERK
and AKT was shown to correlate with differential fates (growth versus differenti-
ation) in PC12 cells [19], and has been implicated in the diverse time to TRAIL
induced apoptosis in HELA cells [76]. For all these examples, detailed mechanistic
understanding of each biological system was necessary to account for the diversity
of responses to external ligands.
Measurement resolution of enzymatic states (e.g. phospho-status) at the single
cell level is requisite for clear identification of properties emerging from complex
nonlinear interactions between signaling network elements. Indeed, nonlinear re-
sponses often rely upon a subset of enzymes that determine the emergent behavior
of the pathway. Identifying these key enzymes uncovers novel vulnerabilities of
the signaling network to inhibition [11]. Examples of nonlinear responses uncov-
ered by single cell measurements are numerous - flow cytometry measurements
of ppERK accumulation in T cell receptor stimulated T lymphocytes exhibited
a highly non-linear bimodal response to antigen [4]. Live single cell imaging of
ppERK activation in response to growth factors was shown to be pulsatile when
measured at the individual cell level [5]. Administration of either the tyrosine ki-
nase inhibitor Gefitnib or MEK inhibitor PD325901 yielded either a frequency or
a mean reduction in ppERK signaling, respectively [3]. Similarly, EGF stimulated
184A1 cells, a mammary epithelial cell line, exhibited oscillatory ERK nuclear lo-
calization (a proxy for activation) with a period invariant to EGF dose, while the
number of cells exhibiting oscillatory behavior reduced markedly with increased
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cell density and decreased EGF concentration [74]. These examples of the diverse
complexities of biochemical signaling networks as unraveled by single-cell mea-
surements were shown to be extremely informative when analyzing the dynamic
structure of a signaling pathway. To our knowledge such combination of single
cell phospho-protein measurements and mechanistic nonlinear dynamical models
of signal transduction remains unexplored during drug development.
In this study, we incorporate single cell multi-parametric phospho-flow cytome-
try measurements, Cell to Cell Variability Analysis (CCVA, [22]), and mechanistic
modeling to dissect the mechanism of action of kinase inhibitors in primary mam-
malian cells. We provide experimental and theoretical evidence that the network
structure in which the targeted enzyme is embedded determines the signaling re-
sponse to inhibition. Furthermore, we investigate the influence of protein expres-
sion variability to the sensitivity of single cells to inhibition. Lastly, we present
experimental results demonstrating the functional relevance of our mechanistic
models of drug inhibition on short timescales to understand drug effects on cell
proliferation on longer timescales.
3.1 pSTAT5 variability in JAK inhibition response origi-
nates with the endogenous variability of STAT5
Reductionist approaches posit that properties of signal transduction pathways in
living cells should be deductible from the biochemistry of its components working
in concert. However, in vitro assays of enzyme extracts - the standard for bio-
chemical characterization of inhibitors - do not incorporate the inherent biological
complexity of cells. To illustrate this issue and establish the relevance of CCVA,
we investigated the biochemistry of drug inhibition for a simple signaling pathway
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- namely, JAK inhibition of the STAT5 phosphorylation response for individual T
lymphocytes stimulated with the cytokine Interleukin 2 (IL-2). IL-2 stimulation
induces the coalescing of the three components of the IL2 receptor [22]. Upon re-
ceptor complex formation, JAK1 and JAK3 - associated with the the intracellular
domains of the receptors γ and β subunits - form an active complex (Figure 3.1A).
The active complex catalyzes the phosphorylation of STAT5 (pSTAT5), which
in turn initiates a large transcriptional response, including cell proliferation and
inhibition of apoptosis [15, 89].
In order to monitor the inhibition of the JAK/STAT pathway at the level of
individual cells, we prepared ex vivo mouse primary T lymphocytes and exposed
them to saturating amounts of the cytokine IL-2 (2 nM) for 10 minutes followed
by varied concentrations of the JAK inhibitor AZD1480 (IJAK) for 15 minutes. In
the absence of drug we observed that the distribution of pSTAT5 among clones is
unimodal with a coefficient of variation of 77 ± 4%. The unimodal distribution
pSTAT5 persisted throughout all doses of JAK inhibitor, while the geometric mean
and coefficient of variation decreased monotonically with increased dosages of the
inhibitory drug (Figure 3.1B). We then measured and tested the average response
of cells to JAK inhibition with an inhibitory Hill function, we measured a half
effective inhibition concentration (IC50) of 8.2 ± 0.5 nM and set the Hill coefficient
to nHill = 1. This lack of cooperativity strongly suggests that JAK inhibition
is a single step process, despite the intrinsic biological complexity in JAK-STAT
activation . In addition, the monotonic decrease in the CVpSTAT5 suggested that the
variation in pSTAT5 among single cell clones does not originate from stochasticity
of chemical reactions with small numbers of reactants. If this were the mechanism
of our observed diversity, the variance of pSTAT5 abundance per cell would scale as
the inverse square root of the mean pSTAT5 abundance [84, 35]. This would result
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Figure 3.1: Variability of endogenous protein abundance correlates with
single cell response to chemical inhibition. (A) IL-2 stimulation of the JAK-
STAT pathway. (B) Single cell pSTAT5 abundance in response to JAK inhibitor
AZD1480. Inset, the coefficient of variation (CV) response to inhibition. (C)
Single cell distribution of the total abundance of STAT5 and pSTAT5 in cells not
treated with inhibitor, [IJAK] = 0. Curve shows the resulting geometric mean of the
pSTAT5 abundance conditioned on STAT5 abundance per cell. (D) Cell-to-Cell
Variability Analysis reveals that the pSTAT5 response amplitude is correlated with
STAT5 abundance and the sensitivity of cells to inhibition is slightly negatively
correlated (error bars are standard deviation of experimental duplicates).
69
in an increase CVpSTAT5 with increase JAK inhibitor concentration. Together these
data suggest a simple biochemical mechanism of inhibition of single cell signaling
and that individual clones have unique internal parameters that manifest as diverse
levels of pSTAT5.
We then focused on elucidating a source of pSTAT5 variability in response to
JAK inhibition. Having ruled out the stochasticity introduced from the physi-
cal properties of biochemical reactions, we decided to measure an observable that
would complement the CCVA framework. We chose to monitor the abundances of
both total STAT5 and pSTAT5 per cell by phospho-flow cytometry [31, 22]. Using
our single cell measurements and CCVA we performed in silico STAT5 titration ex-
periments, and found that the geometric mean of pSTAT5 correlates with STAT5
abundance in the absence of JAK inhibitor (Figure 3.1C). Extending this finding,
we investigated both the JAK inhibitor dose response amplitude and half effec-
tive inhibitor concentration (IC50) with varying abundance of STAT5. Indeed, the
amplitude of pSTAT5 response increased with STAT5 expression as a Hill func-
tion with a Hill coefficient of 1, while the IC50 reduced exponentially with a scale
of approximately -2.02 (STAT5 a.u., Figure 3.1D). Monitoring the extent of drug
inhibition at the single cell level enabled us to establish new experimental obser-
vations regarding signal inhibition e.g. by correlating the cell-to-cell variability of
the response with the heterogeneity of expression of signaling components.
Our preliminary analysis provided detailed quantitative observation regarding
the dependence of pSTAT5 to the endogenous variability of STAT5 abundance,
however it lacks a simple quantitative description of the biochemistry of inhibition
in live cells. To do this we tested three simple biochemical models that may ac-
count for the transmission of STAT5 variability to pSTAT5 levels per cell, and the
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biochemical mechanism of JAK inhibition by the AZD1480 inhibitor - namely non-
competitive, uncompetitive, and competitive inhibition [52, 20]. In the proceeding
sections we describe, in detail, our derivation for equations of each inhibitor model
and our model selection procedure.
3.1.1 Noncompetitive inhibition
STAT5
JAK-STAT5
JAK
JAKI-STAT5 JAKI
IJAK
pSTAT5
Figure 3.2: Noncompetitive inhibitor model Graphical representation of the
noncompetitive JAK inhibitor model. The square symbols represent either a chem-
ical species (filled) or a chemical complex (open). The interaction between chemi-
cal species and complexes is either an equilibrium reaction (lines) or unidirectional
catalyzed reaction (arrows).
Noncompetitive inhibitors bind to their target enzyme irrespective to the pres-
ence of the enzymes substrate. Here, we consider the enzyme substrate to be the
measurable abundance of the STAT5 protein. Although, ATP levels are an impor-
tant consideration, measurements of single cell ATP are beyond the schope of this
work.
To develop a quantitative description of noncompetitive inhibition in living cells
we start by considering the set of mass action chemical kinetic equations governing
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the system:
d
dt
[pSTAT5] = Γ[JAK-STAT5]− λ[pSTAT5], (3.1a)
d
dt
[JAKI-STAT5] = k
IJAK
+ [IJAK][JAK-STAT5]− kIJAK− [JAKI-STAT5]+
k+[JAKI][STAT5]− k−[JAKI-STAT5], (3.1b)
d
dt
[JAK-STAT5] = k+[JAK][STAT5]− k−[JAK-STAT5]− Γ[JAK-STAT5]+
kIJAK− [JAKI-STAT5]− kIJAK+ [IJAK][JAK-STAT5]. (3.1c)
Where we identify the equilibrium reaction parameters as denoted as k+ for the
association of JAK and STAT5, k− represents the dissociation of the JAK-STAT5
complex, and kIJAK± representing the inhibitor forward and reverse rate constants.
The enzymatic reactions of the phosphorylation and dephosphorylation are pa-
rameterized by rate constants Γ and λ, respectively. Conservation of mass dictates
that,
[STAT5total] = [pSTAT5] + [STAT5] + [JAK-STAT5] + [JAKI-STAT5], (3.2a)
[JAKtotal] = [JAK] + [JAKI] + [JAK-STAT5] + [JAKI-STAT5]. (3.2b)
However, we simplify the STAT5 constraint by considering the relative abundance
of both JAK and STAT5 in our experimental system. In our system, Feinerman et
al [30] previously presented values of the abundance of [STAT5total] that are nearly
an order of magnitude greater than the IL2 Receptor β chain. The IL2Rβ chain is
important for it is the limiting component of the active IL2 Receptor, JAK1, and
JAK3 complex [30]. As a result, the total effective abundance of active JAK in
our system ([JAKtotal]) is negligible when considered with the STAT5 abundance
- motivating our approximation of [STAT5total] ≈ [pSTAT5] + [STAT5].
In addition we simplify the dynamic equations by using a quasi-steady state
approximation, which assumes that the binding / debinding kinetics of the equi-
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librium reactions are much faster than the catalytic reactions. This separation of
time-scales between the equilibrium reactions and the catalytic reactions simplifies
the dynamics by setting all the time derivatives of the equilibrium reactions to zero.
Using the quasi-steady state approximation in conjunction with our approximated
constraints we obtain,
1
Γ
d
dt
[pSTAT5] =
[JAKtotal][STAT5]
[STAT5](1 + IJ) + km(1 + IJ kdkm )
− λ
Γ
[pSTAT5]. (3.3)
Here IJ = k
IJAK
+
k
IJAK
−
[IJAK], kd =
k−
k+
, and lastly km =
Γ+k−
k+
. Equation 3.3 can be
simplified further by considering kd
km
in terms of the rate constants
kd
km
=
1
1 +
Γ
k−︸︷︷︸
≈0
≈ 1. (3.4)
Incorporating this approximation and noting that Γ sets the time-scale, we change
to dimensionless units, dτ = Γdt and Λ = λ
Γ
, so that
d
dτ
[pSTAT5] =
[JAKtotal]
(1 + IJ)
[STAT5]
[STAT5] + km
− Λ[pSTAT5]. (3.5)
Our experimental measurements are at steady state for pSTAT5, and are ob-
tained as arbitrary fluorescent units instead of concentrations as required by Equa-
tion 3.5. Therefore, setting the derivative to zero, normalizing by km, and intro-
ducing the parameter φ we arrive at our dimensionless model equation
y =
α
(1 + IJ)
φx− y
(φx− y) + 1 . (3.6)
Where y = [pSTAT5]/km represents our pSTAT5 measurement, φx = [STAT5total]/km
is the adjusted total STAT5 measurement, and α = [JAKtotal]
Λkm
representing the our
pSTAT5 amplitude measurements. The parameter φ is necessary because we apply
the constraint of mass conservation to our dynamic equations, without measuring
our observables in units of absolute number of molecules.
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Figure 3.3: Noncompetitive inhibitor fit to data. (A) The resulting fit of
the data (open circles) with the noncompetitive model (lines) presented in Equa-
tion 3.7. (B) The residuals of the data points from the noncompetitive model fit
for each dose of JAK inhibitor. The color gradient from gray to black represents
increasing AZD1480 concentration, IJAK.
To test the mechanism of inhibition we fit our data to the closed form solution
y =
1
2
φx+ 1 + α
1 + IJ −
√(
φx+ 1 +
α
1 + IJ
)2
− 4α φx
1 + IJ
 . (3.7)
Figure 3.3 demonstrates the excellent agreement of our model with the experimen-
tal data.
3.1.2 Uncompetitive inhibition
The uncompetitive inhibitor is a small molecule that binds exclusively to its tar-
get enzyme while bound to its cognate substrate - in this case the JAK-STAT5
chemical complex (Figure 3.4). Indeed, this mechanism of inhibition manifests
in the equilibrium equations of the drug-enzyme interaction and the conservation
equation for [JAKtotal]. Apart from the inhibitor’s dynamic equations our analysis
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Figure 3.4: Uncompetitive inhibitor model. Graphical representation of the
uncompetitive JAK inhibition model.
remains the same as the noncompetitive inhibitor scenario,
d
dt
[pSTAT5] = Γ[JAK-STAT5]− λ[pSTAT5], (3.8a)
d
dt
[JAK-STAT5] = k+[STAT5][JAK]− k−[JAK-STAT5]− Γ[JAK-STAT5]+
kIJAK− [JAKI-STAT5]− kIJAK+ [IJAK][JAK-STAT5], (3.8b)
d
dt
[JAKI-STAT5] = k
IJAK
+ [IJAK][JAK-STAT5]− kIJAK− [JAKI-STAT5]. (3.8c)
The following mass conservation constraint follows as:
[STAT5total] ≈ [pSTAT5] + [STAT5], (3.9a)
[JAKtotal] = [JAK] + [JAK-STAT5] + [JAKI-STAT5]. (3.9b)
Then applying our quasi-steady state approximation as before we obtain an ex-
pression for the dynamics of pSTAT5,
d
dτ
[pSTAT5] = [JAKtotal]
[STAT5]
[STAT5](1 + IJ) + km − Λ[pSTAT5]. (3.10)
Where IJ = k
IJAK
+ [IJAK]
k
IJAK
−
, km =
k−+Γ
k+
, and [STAT5] = [STAT5total] − [pSTAT5].
Solving for the unitless variables describe in Equation 3.6, we obtain
y =
α
1 + IJ
φx− y
φx− y + 1
1+IJ
. (3.11)
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This representation provides a transparent understanding of the difference between
the noncompetitive and uncompetitive inhibitor. Unlike the noncompetitive in-
hibitor which reduces the response amplitude exclusively (i.e. α), the uncompeti-
tive inhibitor effectively reduces both the response amplitude and the half effective
inhibition concentration.
We conclude by presenting the closed form solution used to fit the data (Fig-
ure 3.5)
y =
1
2
[
φx+
1 + α
1 + IJ −
√(
φx+
1 + α
1 + IJ
)2
− 4α φx
1 + IJ
]
. (3.12)
In Figure 3.5 we see that the model introduces systematic error in estimating
pSTAT5 levels for cells with low expression of STAT5.
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Figure 3.5: Uncompetitive inhibitor model fit. (A) The resulting fit of the
data (open circles) and the uncompetitive model (lines) represented by Equa-
tion 3.12. (B) The residuals of the data points from the uncompetitive model
fit for each dose of JAK inhibitor. The color gradient from gray to black repre-
sents increasing AZD1480 concentration, IJAK.
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Figure 3.6: Competitive inhibitor model. Graphical representation of the
competitive inhibition model.
3.1.3 Competitive inhibition
Competitive inhibitors compete with the substrate for binding to the target en-
zyme. Apart from the difference in the dynamic equations describing the unique
mechanism of action, the proceeding analysis utilizes the same approximations as
the previous two sections. Incorporating the inhibitor mechanism of action into
the dynamics
d
dt
[pSTAT5] = Γ[JAK-STAT5]− λ[pSTAT5], (3.13a)
d
dt
[JAK-STAT5] = k+[STAT5][JAK]−
k−[JAK-STAT5]− Γ[JAK-STAT5], (3.13b)
d
dt
[JAKI-STAT5] = k
IJAK− [JAKI]− kIJAK+ [IJAK][JAK]. (3.13c)
As before we approximate the mass conservation equations of constraint as
[STAT5total] = [pSTAT5] + [STAT5], (3.14a)
[JAKtotal] = [JAK] + [JAK-STAT5] + [JAKI]. (3.14b)
Applying our quasi-steady state approximation
d
dτ
[pSTAT5] = [JAKtotal]
[STAT5]
[STAT5] + km(1 + IJ) − Λ[pSTAT5], (3.15)
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with IJ = k
IJAK
+ [IJAK]
k
IJAK
−
, km =
k−+Γ
k+
, and [STAT5] = [STAT5total] − [pSTAT5]. As
before we proceed by solving for the non-dimensional variables describe in Equa-
tion 3.6 and arrive at
y = α
φx− y
(φx− y) + 1 + IJ . (3.16)
From this equation we can clearly identify the unique functional difference between
the noncompetitive and uncompetitive inhibitors with the competitive inhibitor.
Unlike the former two equations (Eqs 3.6,3.11) representing the JAK inhibitor ac-
tion, the competitive inhibitor increases the half effective concentration of STAT5.
The closed form solution used to fit our data is
y =
1
2
[
φx+ α + 1 + IJ −
√
(φx+ α + 1 + IJ)2 − 4αφx
]
. (3.17)
Figure 3.7, shows the large systematic error of this model in approximating our
experimental data.
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Figure 3.7: Competitive inhibitor model fit. (A) The resulting fit of data
(open circles) and the competitive inhibitor model model represented in Equa-
tion 3.17 (lines). (B) The residuals of the data points from the uncompetitive
model fit for each dose of JAK inhibitor. The color gradient from gray to black
represents increasing AZD concentration, IJAK.
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3.1.4 Model selection
To find the most likely mechanism of action of AZD1480 in living cells we measured
the ability of each possible model to explain our data. Each model is represented
as a function fi, for i = {Noncompetitive, Uncompetitive, Competitive}, derived
for each mechanism of inhibition. We measured the sum of squared residuals (i)
for each model with respect to our data,
i =
N∑
l=1
M∑
m=1
(
yl,m − fi
(
[IJAK]l, xm; ~θi
))2
where ~θi = {αˆi, φˆi, kˆI i}, (3.18)
to obtain an estimate of the goodness of fit. In this equation N is the number
of inhibitor doses and M is the number of CCVA determined STAT5 data points.
The mechanism of inhibition is determined by selecting the model function, and
the corresponding optimal parameters ~θi, that exhibit the smallest sum of squared
residuals.
There exists several methods for optimal model selection; we chose the mini-
mization of the sum of squared residuals as our criteria because of the simplicity
of our considered models. Specifically, each model that was considered consisted
of the same number of parameters (complexity) making techniques aimed at quan-
titatively compromising between model complexity with statistical accuracy not
necessary (e.g. BIC and AIC).
We found that the noncompetitive inhibition model (Equation 3.7) for AZD1480
action best described our experimental observations (smallest , Figure 3.8A). Bi-
ologically, this mechanism is intuitive, because this inhibitor has been documented
to compete with ATP for occupancy of the ATP binding pocket of JAK and not
STAT5 [55]. We further quantified the agreement of our model fit by measuring a
coefficient of determination (R2) of 0.95 (Figure 3.8B) of data linearized according
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Figure 3.8: CCVA reveals the most likely mechanism of AZD1480 in live
single cells. (A) Each model was tested against our data by measuring the sum
of squared residuals of our model predictions to the data points (total residuals).
(B) Linearized data according to the coordinate transform (Eq 3.19) of the optimal
model and estimated parameters reveal excellent agreement between model (line)
and data (open circles), R2 = 0.95. (C) Overlay of measured IC50 with respect to
STAT5 abundance as measured from CCVA analysis of data (triangles, error bars
standard deviation experimental duplicates) and predicted by our optimal model
(line).
to
ydata
(
1 + IˆJ
)(
φˆxdata − ydata + 1
)
︸ ︷︷ ︸
Normalized pSTAT5
= αˆ(φˆxdata − ydata)︸ ︷︷ ︸
Normalized STAT5
. (3.19)
Eq 3.19 represents a rearrangement of Eq 3.6 for parameter values estimated from
the data (Table 3.1). Lastly, we validated that our model could account for the
small dependence of the IC50 on STAT5 expression. We see excellent agreement
between our IC50 measurements in Figure 3.1D with the estimated IC50 from our
model (Figure 3.8C).
Table 3.1: Noncompetitive inhibitor parameter estimates Parameters ob-
tained from least-square fits of Equation 3.7 to our experimental data.
Parameter Interpretation Rep 1 Rep 2 Mean
φ prefactor for total STAT5 expression 4.13 5.05 4.59
α normalized amplitude 5.65 5.32 5.49
kI inhibitor dissociation constant 5.33 nM 4.93 nM 5.13 nM
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3.2 Inhibition of TCR induced MAPK in T lymphocytes
We investigated the inhibition of a large signaling cascade, namely antigen-driven
MAP kinase activation in primary mouse T lymphocytes (T cells). Upon exposure
with activating ligands (e.g. complex of a peptide with Multi-Histocompatibility
Complex on the surface of antigen presenting cells), T cells activate their receptors
(TCR), through activation of a SRC Family Tyrosine Kinase (SRC) (e.g. Lck a SRC
family kinase bound to CD8), which, in turns, trigger a cascade of kinase activation
leading to ERK phosphorylation (Figure 3.9). We chose this model system because
its complex network topology and its functional relevance: aberrant activation in
the ERK pathway is often involved with oncogenesis [37], making it a key pathway
to be targeted with drug inhibitors in multiple tumor settings.
3.2.1 Single cell measurements reveal diverse modes of in-
hibition
We decompose TCR mediated activation of ERK into two smaller subnetworks:
1) a receptor proximal signaling cascade with positive and negative feedback reg-
ulation, and 2) the unidirectional MAP kinase (MAPK). We hypothesized that
applying inhibitors that target enzymes specific to each signaling subnetwork will
produce unique responses in terms of ERK phosphorylation.
We tested our hypothesis by administering inhibitors targeting the two signal-
ing subnetworks - a SRC inhibitor (Dasatinib) for the receptor proximal component
and a MEK inhibitor (PD325901) for the MAPK component - in activated T cells.
Measuring the average response of cells to both inhibitors (Figure 3.10A) results
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CD8
Figure 3.9: TCR signaling biology. Reprinted by permission from Macmillan
Publishers Ltd: Nature Chemical Biology [86], copyright (2012).
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in amplitude reduction and a trivial inhibition model. However, upon applying
our single cell methodology (as introduced in the previous section), we found that
ppERK signaling exhibits an all or none (bimodal) response (Figure 3.10B)- con-
sistent with previous studies of T lymphocyte [4] and MCF10A cell activation
[3]. Analyzing the single-cell response to Dasatinib, the SRC inhibitor, shows a
bimodal response - individual cells transition from maximal to undetectable quan-
tities of ppERK (Figure 3.10B,D). Meanwhile, application of PD325901, the MEK
inhibitor, exhibits an analog response - a reduction in ppERK amplitude with dose
(Figure 3.10C,E). Dasatinib and PD325901 exhibit differential modes of ppERK
inhibition.
Measurements of the drug response by canonical parameters - IC50 and ampli-
tude - at the bulk level failed to reveal disparate modes of inhibition as observed
at the individual cell level (Figures 3.10D,E). We characterized the two modes
of inhibition by fitting the distribution of ppERK abundance per cell to a Gaus-
sian mixture model, whose statistics can be summarized with two parameters -
µ+ for the mean logarithmic measurement of ppERK among activated cells and
α+ for the fraction of activated cells (Figure 3.10F) - at each dose of inhibitor.
In Figure 3.10G, we report that MEK inhibitor operates solely upon the mode
of ppERK abundance among activated cells, µ+ and acts as a analog inhibitor of
ERK activation; SRC inhibitor upon the fraction of active cells, α+ and acts as a
digital inhibitor. Similar results were obtained using genetically-modified cell lines
that express reporters of ERK activity; our single-cell phospho-profiling method-
ology has the added advantage of being applicable to primary cells (e.g. taken
from patients), without added modification. Hence, by utilizing single-cell mea-
surements, we were able to demonstrate that there exist two modes of inhibition
in the MAPK signaling cascade: analog (when µ+ varies with drug concentration)
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Figure 3.10: Inhibitor target specific modes of inhibition. (A) The implicit
model of inhibitor action. (B) Histograms of single T cell response to simulta-
neous TCR stimulation and SRC inhibition with Dasatinib. (C) Histograms of
single T cell response to simultaneous TCR stimulation and MEK inhibition with
PD325901. (D) Single cell Dasatinib dose response of TCR activated T cells - inset
represents the mean response of all cells. (E) Single cell PD325901 dose response
of TCR activated T cells - inset represents the mean response of all cells. (F)
Single cell data were modeled as a mixture of Gaussian distributions, where α+
represents the fraction of activated cells, and µ+ represents the average abundance
of ppERK among activated cells. (G) The (µ+,α+) plane shows the orthogonal
modes of inhibition (error bars are standard error of mean from 100 samples of 500
T cells per dose of inhibitor chosen randomly and with replacement).
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or digital (when it is α+ that varies with drug concentration). Both modes of
inhibition can be associated with different enzymes at different stages of the ERK
cascade.
3.2.2 Coarse grained model of TCR activation of ERK
We next sought to test whether the enzymatic context, i.e. the position of the en-
zyme undergoing inhibition within the transduction cascade, would explain the two
distinct modes of inhibition (analog vs digital) observed in Figure 3.10. We devel-
oped a coarse grained model accounting for ERK phosphorylation downstream of
SRC activation [4, 31, 32] in order to generate mechanistic understanding and ac-
tionable predictions to be validated. Our model explicitly incorporates measurable
quantities, control parameters, and the inhibitor targeted species while coarsening
the large biological complexity of this signaling cascade into a phenomenological
biochemical species of activated SRC associated with the engaged ligand/receptor
complex (denoted SRC∗). The graphical representation of our model (Figure 3.11)
emphasizes the two subnetworks at stake here : 1) active SRC (SRC∗) is controlled
by competing positive and negative feedbacks, and 2) MEK and ERK are activated
upon formation of SRC∗ in a unidirectional manner (no feedback). These modeling
components encompass key features of ERK activation in the context of antigen
activation in T lymphocytes [4, 31, 32], without loss of generality.
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Figure 3.11: Coarse-grained TCR signaling model. Empty squares designate
chemical complexes, while filled squares are independent chemical species. Arrow-
less lines connecting two squares indicates an equilibrium reaction, while lines with
arrows indicate enzymatic reactions.
The components interact according to mass action differential equations:
d
dt
[SRC∗] = k+[L−R][SRC]− k−[SRC∗]+
k+[L−R][SRC] Γ+[SRC
∗]n
[SRC∗]n + knm+
− k− Γ−[SRC
∗]
[SRC∗] + km−
+
kIs−[SRC
∗
I ]− kIs+[SRC∗][ISRC], (3.20a)
d
dt
[SRCI] = k
Is
+[SRC][ISRC]− kIs−[SRCI]+
k−[SRC∗I ]− k+[SRCI][L−R], (3.20b)
d
dt
[pMEKtotal] = ΓM
[SRC∗]N
[SRC∗]N + kN
− λ[pMEKtotal], (3.20c)
d
dt
[MEKI] = k
Im
+ [pMEK][IMEK]− kIm− [MEKI], (3.20d)
d
dt
[ppERK] = ΓE[pMEK]− λ[ppERK]. (3.20e)
In this model all equilibrium rate parameters are represented using kθ+,− notation,
where (+,−) represent the forward and reverse rates respectively and θ provides
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the corresponding reaction identity. Specifically, no superscript represents the
L− R and SRC interaction, ‘Is’ superscript is the SRC and ISRC interaction, and
lastly ‘Im’ superscript is the pMEK and IMEK interaction. The feedbacks are pa-
rameterized by the half effective concentration constants for the forward reaction
km+ and the reverse reaction km−, the hill coefficient of the positive feedback n,
and the positive (Γ+) and negative (Γ−) feedback strengths. Lastly, all dephos-
phorylation rates, λ, are identical.
Analysis of the equations are broken into two subnetworks - first the dynamics
of [SRC∗], followed by those of [MEK] and [ppERK]. To analyze the dynamics of
[SRC∗] we first define the constraints originating from mass conservation,
[SRCtotal] = [SRC] + [SRC
∗] + [SRCI] + [SRC∗I ], (3.21a)
[L−Rtotal] = [L−R] + [SRC∗] + [SRC∗I ]. (3.21b)
In our experiments we administer saturating doses of antigen bound to peptide
MHC on antigen presenting cells, [L − Rtotal]  [SRCtotal], making [L − Rtotal] ≈
[L − R] a reasonable approximation. Furthermore, we apply a quasi-steady state
approximation in which all equilibrium reactions are much faster than enzymatic
reactions. Together we see that
[SRC] =
[SRCtotal]
1 + [ISRC]
ksrcI
− [SRC∗] (3.22)
with ksrcI = k
Is
−/k
Is
+.
We continue by normalizing our data by km+ allowing us to rewrite the dy-
namics of [SRC∗] by the unitless variable x. Specifically we take x = [SRC∗]/km+,
α = km−/km+, st = [SRCtotal]/km+, Γ−/km+ = Γ
′
−, and Is = [ISRC]/ksrcI to obtain
1
Γ′−k−
d
dt
x =
Γ+[L−R]
Γ′−kd
[
1
Γ+
+
xn
xn + 1
] [
st
1 + Is − x
]
−
[
1
Γ′−
+
1
x+ α
]
x. (3.23)
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Throughout our experiments we do not change the quantity of antigen or antigen
presenting cells allowing us to group Γ+[L−R]
Γ′−kd
into a single dimensionless parameter
A1. Furthermore, we take the feedback amplitudes to be much larger than 1,
resulting in 1
Γ+
, 1
Γ′−
→ 0 and a simpler expression for x,
d
dτ
x ≈ A1 x
n
xn + 1︸ ︷︷ ︸
Positive Feedback
Mass conservation︷ ︸︸ ︷[
st
1 + Is − x
]
− x
x+ α︸ ︷︷ ︸
Negative Feedback
. (3.24)
This simplified equation of the dimensionless variable x provides a function for
analyzing the topology dependent response of our experimental system to SRC
inhibition. To find the values of x at the fixed points of the system we numerically
evaluated the stationary solution to Equation 3.24.
The second subnetwork of our system represents the dynamics of [pMEK] and
[ppERK]. The MEK inhibitor binds to free pMEK, which results in an inactive
complex MEKI. As a result the total pMEK (pMEKtotal) produced by SRC
∗ exists
in two states. To link the dynamic equation governing [pMEKtotal] (Eq 3.20c) with
the uninhibited pMEK species - the species that produces our quantity of interest
([ppERK]) - we write the following mass conservation equation [pMEKtotal] =
[pMEK] + [MEKI]. In addition, we assume that the kinetics of the drug binding to
pMEK are much faster than the enzymatic reactions. Incorporating the constraint
and approximation we see that [pMEKtotal] = [pMEK](1 + k
mek
I ), allowing us to
proceed by writing an expression for the dynamics of [pMEK] with respect to
Eq 3.20c as
d
dt
[pMEK] =
ΓM
1 + Im
[SRC∗]N
[SRC∗]N + kN
− λ[pMEK]. (3.25)
We continue by rewriting the expression with respect to the unitless variables
d
dτ
m =
γm
1 + Im
xN
xN + kNx
− Λm. (3.26)
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Where γm =
ΓM
km+k−Γ′−
, Λ = λ
k−Γ′−
, x = [SRC∗]/km+, and m = [pMEK]/km+. Similar
to the dynamic equations for unitless pMEK the dynamics of [ppERK] in Eq 3.20e
can be rearranged,
d
dτ
y = γem(τ)− Λy, (3.27)
where γe =
Γe
k−Γ′−
and y = [ppERK]/km+.
By solving the differential equation for m we can simplify our system of three
equations to two. Two simple dynamic equations is ideal, because the system
properties can be easily interpreted in a single two-dimensional phase diagram
(Figure 3.12). The m equation can be described by the following integral equation
m(τ) =
γm
Λ
1
1 + Is
 xN(τo)xN(τo) + kNx e−Λ(τ−τo)︸ ︷︷ ︸
A
+ Λ
∫ τ
s>τo
xN(s)
xN(s) + kNx
e−Λ(τ−s)ds︸ ︷︷ ︸
B
 .
(3.28)
The integral equation representation provides transparency to the systems behavior
at the initial conditions, τ = τo (A), and the resulting dynamics, τ > τo (B).
Because we are studying the dependence of the instantaneous flux for different
x(τo) and y(τo) we set the B term to zero. Substituting for m and γmγe/Λ
2 = A0,
the initial fluxes are described as
d
dτ
x(τ)
∣∣∣∣
τ=τo
= A1
x(τo)
n
x(τo)n + 1
[
st
1 + Is − x(τo)
]
− x(τo)
x(τo) + α
,
d
dτ
y(τ)
∣∣∣∣
τ=τo
=
ΛA0
1 + Im
x(τo)
N
x(τo)N + kNx
− Λy(τo).
(3.29a)
(3.29b)
The Equations 3.29 represent the instantaneous flux and are used for the stream
plots of the [ppERK] versus [SRC∗] (y and x) phase planes in Figure 3.12. We pro-
ceed by finding the properties of our equations that are experimentally measured
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- namely the locations and the respective stabilities of the stationary values,
0 = A1
xn
xn + 1
[
st
1 + Is − x
]
− x
x+ α
,
y =
A0
1 + Im
xN
xN + kNx
.
(3.30a)
(3.30b)
We evaluated the fixed points of x and their corresponding stability numerically in
accordance to Eq 3.30a. The stability of each fixed point was assessed by numerical
evaluating the direction of the flux, positive or negative, for small displacements
about the respective fixed point. Given our chosen parameter set (Table 3.2), we
found our system to elicit bistable behavior [78].
Table 3.2: TCR model parameters. Parameters used for all TCR modeling
figures.
Parameter Interpretation Assignment
A1 Effective x forward rate constant 1.75
st Quantity of dimensionless [SRCtotal] 2.5
n steepness of positive feedback 3
α negative feedback sensitivity / positive feedback sensitivity 0.1
A0 Effective y production constant 1
kx sensitivity of y to changes in x 0.5
N hill coefficient of MAPK 4.
Λ Effective y degradation constant 1.
To develop intuition regarding the properties of our competing feedback model
we constructed phase diagrams of active SRC that demonstrate how varied quan-
tities of SRC∗ map to ERK phosphorylation. SRC∗ originally accumulates upon
engagement of the activating ligand with its kinase-bearing receptor. This subse-
quently activates both positive and negative feedback on further accumulation of
SRC∗. The dynamics of accumulation of SRC∗ can be summarized in a phase di-
agram (Figure 3.12B), that illustrates the influence of both feedbacks. The model
parameters are set so that the negative flux (or time derivative of SRC∗) rises and
saturates at lower levels of SRC∗ than the positive flux (Table 3.2). This stag-
gering of the positive and negative fluxes as a function of SRC∗ causes them be
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equal at three points in the phase diagram, i.e. there are three stationary or fixed
points. By plotting the net flux as a function of the active complex SRC∗, one can
assess the stability of the fixed points. The dynamics are such that SRC∗ always
converges to the extreme points SRC∗low and SRC
∗
high (stable fixed points), while
diverging from the center point SRC∗med (unstable fixed point). This encapsulates
the bistability in SRC∗ formation. We then model ERK activation by assuming
that the active complex SRC∗ enzymatically phosphorylates MEK, which then pro-
portionally phosphorylates ERK (Figure 3.12C). In Figure 3.12D, we represent the
dynamic trajectory of this signaling pathway for varied initial conditions: such flow
diagram illustrates the stability of the low and high states in the (SRC∗,ppERK)
plane, the instability of the intermediate point. Overall, our coarse grained model
of ERK activation upon ligand engagement generates two stable fixed points cor-
responding to either zero or maximum ppERK, consistently with our experimental
results.
We then tested how our coarse-grained model would predict ERK response to
drug inhibition. Application of the MEK inhibitor to our model (Figure 3.12E)
supports our experimental observations. Inhibition of MEK does not influence
the bistability of the activated kinases SRC∗ (Figure 3.12F), and does not itself
support nonlinearities. Titrating the MEK inhibitor shows continuous reduction
in the amplitude of ppERK response (Figure 3.12G). Figure 3.12H explicitly shows
that the dynamic properties supporting the bistability in ppERK are preserved in
the presence of the MEK inhibitor. Our model is validated with the experimental
observation that the MEK inhibitor only reduces the average quantity of ppERK
of the activated cells i.e. it inhibits the ERK pathway in an analog manner.
SRC is the kinase that is critical to establish the bistability of the active complex
91
SRCi TCR model
L-R SRC
SRCI
ISRC
SRC⇤I
ppMEK
ppERK
Equilibrium Reaction
Enzymatic Reaction
Enzymatic Inhibition
Figure 4
I
E
D
F
J K L
G
B
H
C
Stable Fixed Point
Unstable Fixed Point
Chemical Species
Chemical Complex
A
MEKi model
L-R
SRC⇤
SRC
pMEK
MEKI IMEK
ppERK
TCR model
L-R
SRC⇤
SRC
pMEK
ppERK
[IMEK] [IMEK]
[ISRC] [ISRC]
Figure 3.12: Subnetwork context of the targeted enzyme determines re-
sponse to inhibition. (A) Model diagram of signaling network. (B) Phase plane
of SRC∗, inset shows the behavior of both the positive and negative model fluxes.
(C) Functional response of ppERK to changes in SRC∗ abundance. (D) Instanta-
neous reaction velocities given ordered pairs of (SRC∗, ppERK) shows the dynamic
behavior of the model system. (E) Model diagram for MEK inhibition of signaling.
(F,G) Analogous to representations of model behavior as (B,C) but for different
doses of MEK inhibitor. (H) Instantaneous reaction velocities for maximal MEK
inhibition. (I) Model diagram for SRC inhibition. (J,K) Analogous representa-
tions of SRC inhibition as (F,G) for MEK inhibition. (L) Instantaneous reaction
velocities for maximal SRC inhibition show that the dynamics support a single
fixed point at (SRC∗, ppERK) = (0,0).
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SRC∗, resulting in a signaling context fundamentally distinct to that of pMEK.
Inhibition of SRC reduces the positive flux generating SRC∗ (Figure 3.12I), and
consequently reduces SRC∗ at the high fixed point. Increasing the dose of the
SRC inhibitor decreases SRC∗ until, at a critical dose, the high fixed point and the
unstable fixed point annihilate one another (Figure 3.12J). Doses of SRC inhibitor
greater than the critical dose result in a system with a single fixed point, SRC∗=
0 (Figure 3.12J). Despite continuous reduction of the high stable fixed point with
increased dosage of SRC inhibitor, quantities of ppERK remain negligibly changed
until the inhibitor is greater than the critical dose (Figure 3.12K). For doses of
SRC inhibitor beyond the critical dose the signaling network only supports a single
quantity ppERK at zero (Figure 3.12L). Hence, SRC inhibition results in a binary
output that is identical to that observed in the data: our model is consistent with
the digital nature of Dasatinib as a SRC inhibitor.
Our model assumed that interactions of molecular inhibitors with their target
enzyme all act as noncompetitive inhibitors with respect to the biochemical sub-
strate. Yet, this biochemically identical mechanisms of drug inhibition is sufficient
to account for the two distinct modes of inhibition of ERK in our experimental
findings. Thus, our results and theoretical model demonstrate that enzymatic
context is an essential component for parameterizing inhibitor function in living
cells.
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3.2.3 Variability in protein abundance diversifies sensitiv-
ity of signaling pathway to targeted inhibition
Using our mechanistic model, we sought to explore how the endogenous variability
of SRC abundance would diversify the response of individual cells to inhibition.
Our model predicted that the effective quantity of SRC determines whether the
(SRC, ppERK) phase diagram has a single or three fixed points - as a result
it represents a bifurcation parameter. By analogy, endogenous variation of SRC
positions cells above and below the critical quantity of SRC required for bistable
signaling (Figure 3.13A). We tested this model generated hypothesis by measuring
CD8 (as a proxy for the abundance of SRC) and ppERK of activated T cells.
Indeed, in T cells LCK, a Tyrosine kinase is recruited by CD8 for receptor signaling,
therefore we assumed that CD8 abundance could act as a proxy for the effective
abundance of SRC in individual cells. Indeed, measuring CD8 for a single dose
of SRC inhibitor shows that cells with elevated quantities of CD8 are more likely
to have ppERK signal (Figure 3.13B), a result that is consistent with previous
experimental and theoretical observations [31]
Extending this observation, our model suggests that the variability of CD8
expression in single cells is sufficient to generate disparate sensitivities to drug in-
hibition. The bifurcation diagram for each drug dose, Figure 3.13C, shows that the
minimum quantity of SRC sufficient for the bistability, SRCc, increases with drug
dose. Consequently, a cell with a higher quantity of SRC will be more tolerant to
inhibition because of simple dosing of the available SRC (Figure 3.13D) - requiring
higher inhibitor dosage to experience any reduction in signaling.
Indeed, CD8 abundance per cell does not perfectly predict whether a cell is
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capable of signaling (Figure 3.13B). As a result we estimated the half effective
abundance of CD8 (a.u.) as an effective measure of CD8’s contribution to tuning
the sensitivity of individual cells to drug. We call this quantity, CD8c, and estimate
it by fitting the fraction of cells signaling to a hill function,
f(CD8; CD8ci, ~θi) = θ0i
CD8θ1i
CD8θ1i + CD8θ1ici
+ θ2i, (3.31)
dependent on CD8 abundance for each, i, dose of inhibitor. In Equation 3.31
θ0 represents the maximum fraction of cells that can signal, θ1 represents the
sharpness of the CD8 dependency, and lastly θ2 is the minimum fraction of cells
that can signal. The data were fit to Equation 3.31 by minimizing the sum-square
residuals with the constraint that θ2 ≥ 0 - no other constraints were required.
The output of our procedure is summarized in Figure 3.13E which shows the
amplitude (θ0i) normalized data and the corresponding hill fits. We applied this
procedure to both the MEK inhibitor and SRC inhibitor data, and confirmed our
predictions that the MEK inhibitor reduced ERK activation independently of the
levels of CD8 while higher concentrations of SRC inhibitor correlated with a higher
CD8c (Figures 3.13F).
3.2.4 Diverse signaling responses to drug inhibition on short
time-scales translate into diverse cell proliferative re-
sponse on long time-scales.
Upon phosphorylation, ERK migrates from the cytosol to the cell nucleus where it
induces the expression of the immediate and early genes (IEGs, e.g. cFOS). IEGs
constitute a set of genes that facilitate cell cycle entry and cell division [57], hence
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Figure 3.13: Protein variability tunes sensitivity of cells to inhibition. (A)
Mechanistic model reveals that the endogenous expression of SRC functions as a
bifurcation parameter. (B) Flow cytometry measurements of T cells concomitantly
labeled for CD8 (a proxy for SRC) and ppERK (pT202, pY204) shows signaling
dependence to endogenous expression of CD8. (C) Model predictions of SRCc de-
pendence with SRC inhibitor dose. (D) Model predicts scaling of SRCc with in-
creasing doses of a SRC inhibitor and not a MEK inhibitor. (E) CCVA of T cells
concomitantly labeled for CD8 and ppERK (pT202, pY204) treated with various
doses of the SRC inhibitor Dasatinib. (F) Quantification experimental data of the
half effective abundance of CD8 (CD8c) required for ppERK activation in T cells
treated with either MEK inhibitor (PD325901) or SRC inhibitor (Dasatinib).
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one functional readout of ERK activation is the overall cell proliferation response.
Based on our signaling results (Figure 3.10), we conjectured that intermediate
levels of pERK from titrating a MEK inhibitor may induce slower induction of
IEGs, and as a result would increase the time to cell division. In contrast, titrating
a SRC inhibitor would change the fraction of cells entering the cell cycle as its does
with the fraction of cells maximally inducing ppERK, without affecting the overall
cell division among activated cells (cf Figure 3.10) [3].
We tested this hypothesis by quantifying the cell proliferation of T cells af-
ter 48 hours of in vitro culture under concomitant antigen stimulation and drug
exposure. We monitored cell activation and division by measuring cell size, the
levels of the CD8 coreceptor on surface of cells, and the fluorescence of T cells
that were tagged before activation with the amine-reactive fluorescent dye CTV
or CFSE (the dye gets diluted by two at each cell division) by flow cytometry.
Upon activation cells increase both their size and CD8 expression, providing a
clear criteria separating active and inactive cell populations, whose numbers can
be quantified as N± respectively (Figure 3.14A). We then analyzed the number of
cells (N±i for i = {0, 1, 2, 3}) undergoing i divisions as measured by CTV dilution
(Figure 3.14B). We computed the average number of divisions as,
〈
Divisions±
〉
=
1
N±total
nmax∑
n=0
N±n
2n
n, (3.32)
where Nn is the number of cells in the n division gate, and
N±total =
nmax∑
n=0
N±n
2n
. (3.33)
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Meanwhile, the fraction of activated cells are computed as,
Fraction Active =
〈
Divisions+
〉〈
Divisionsall
〉 (3.34)
=
Nalltotal
N+total
∑
n
N+n
2n
n∑
n
Nalln
2n
n
(3.35)
= Active Fraction
∑
n n
N+n
2n∑
n n
Nalln
2n︸ ︷︷ ︸
Gate correction
. (3.36)
We have found that computing the active fraction in this way increases the ro-
bustness of the analysis. For many doses, simple gating of active and inactive
populations resulted in the bifurcation of what appeared as a single distribution
of cells. By adding the extra information that only the active cells proliferate
and divide, we can correct for the error in estimating the active fraction that is
introduced by the simple gating analysis.
Representing the data with respect to (mean divisions, active fraction) clearly
demonstrates how the disparate modes of inhibition from signal transduction map
to the proliferative timescale. Furthermore, we see that the mode of inhibition
depends solely on the inhibitor target species and not the identity of chemical
inhibitor applied (Figure 3.14C). Explicitly, we see that dosing a MEK inhibitor
reduces the average number of divisions among activated cells. While the dominant
feature of the SRC inhibition is the distinct reduction of activated cells. Indeed, the
fraction of activated cells is the dominant but not the exclusive feature observed in
our data, intermediate dosages of SRC inhibition does reduce the mean divisions.
While our model does not produce insight to this phenomena, it is not surprising,
because of the unaccounted signaling transduction pathways dependent on TCR
activation, e.g. PI3K and AKT [87].
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Figure 3.14: Short time scale modes of inhibition translate to long
timescale proliferative response. (A) Identification of activated T cells af-
ter 48 hours of concomitant treatment with antigen and the respective inhibitor
measured by flow cytometry. Upon activation, cells increase size, measured by for-
ward scatter area (FSC-A), and up-regulate surface protein CD8. (B) Cell trace
violet (CTV) dilution identifies active cells that have divided n times. (C) Quan-
tification of fraction of active cells and mean number of divisions for each chemical
inhibitor.
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3.3 Summary
In this study we use a combined theoretical and experimental approach to extend
the mechanistic understanding of chemical inhibitors to living cells. We use single
cell phospho-profiling and Cell to Cell Variability Analysis (CCVA) [22] to per-
form detailed biochemical characterization of small molecule chemical inhibitors -
to date such detail has been limited to in vitro enzymatic assays. We also uncov-
ered a generalizable mechanism in which targeted enzyme inhibition manifests to
unique patterns of inhibition, digital and analog. Lastly, we probed the biologi-
cal significance of these results from short-timescale signaling behavior to unique
modes of inhibition of cellular proliferation.
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CHAPTER 4
CONCLUDING REMARKS
In this work we presented results demonstrating the signatures of biological
variability at the molecular scale. In doing so, we developed tools to study the
transmission of fluctuations in the abundance of biochemical species throughout
gene regulatory networks and biological signaling systems. We have also shown
how single cell measurements elucidate complex phenomena of signaling pathways
when perturbed by small molecule chemical inhibitors. Moreover, we showed how
the endogenous variability of protein can diversify the response of individual cells
to chemical inhibition. This introduced diversity provides sufficient data to per-
form detailed biochemical titration analysis of chemical inhibitors in living systems.
Taken together, we have made progress in understanding diversity at the molec-
ular scale, and may facilitate understanding the molecular origins of non-genetic
phenotypic variability observed in biological systems.
4.1 Propagation of biochemical fluctuations
Biological systems utilize networks of biochemical interactions to process informa-
tion regarding their environment and illicit appropriate physiological responses.
Indeed, these systems are constrained by the stochastic properties of their molec-
ular constituents, namely stochasticity of the chemical reactions. Moreover, bio-
chemical systems are complex, representing an aggregate of stochastic processes
that manifest as fluctuations of molecular components that exceed those predicted
by one step stochastic processes [82, 73, 33]. Consequently, appropriate descrip-
tions of the fluctuations in the abundance of molecular components must reflect
these long tailed distributions. To solve this problem, we developed a chemical
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Langevin equation of the logarithmic concentrations of molecular species in ac-
cordance with single cell experimental observations (Figures 2.2,2.6). With this
equation we derive a Lyapunov equation (Eq 2.29) to study the transmission of
biological fluctuations of molecular components theoretically and validate these
results in two experimental model systems: a synthetic E. coli gene regulatory
network and mammalian phospho-signaling.
A premise of our analysis is that fluctuations in the abundance of biochemical
species are approximately log-normal. To account for these log-normal fluctu-
ations we derived a chemical Langevin equation of the logarithmic biochemical
concentrations by considering fluctuations of rate parameters and asserting that
the magnitude of the fluctuations are independent of network activity. Indeed, our
consideration of parameter fluctuations is purely empirical. However, we have two
sources of experimental evidence of this description. First, we are able to describe
the propagation of fluctuations in biochemical components by analyzing the re-
sulting covariance and variance plots in E. coli (Figure 2.11) and T lymphocytes
(Figure 2.13). Moreover, in each set of measurements, the covariance of maximal
and minimal network activity were identical. This suggests that the fluctuations in
our experiments are not dominated by extrinsic sources. Indeed, extrinsic sources
of variability would manifest in covariances that differ at maximal and minimum
stimulation. In addition, we used our model to estimate the magnitude of in-
ternal noise as it depends on the activity of the pathway. We report that the
internal logarithmic fluctuations in T lymphocyte phospho-signaling is invariant
to the pathway activity (Figure 2.16). Together, these results justify our analysis,
yet more detailed investigation to the precise origins are needed (e.g. single cell
temporal measurements of each process).
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The utility of our approach comes from our derived Lyapunov equation (Equa-
tion 2.29). This equation provides a description of the covariance matrix as a
function of both the network connectivity and the internal noise. From this equa-
tion, we showed how different network structures produce unique functional re-
lationships between covariance matrix elements. Analysis of these elements with
changing connectivity strengths provides signatures of the network structure. In-
deed, when comparing a pair of interacting biochemical species, the downstream
molecule will sum its internal fluctuations and those propagated from its upstream
partner. This intuition is captured by plotting the data in the covariance and
variance plane. For example, in the isolated two node interaction the down stream
molecule increases its variance as the square of the covariance. Meanwhile the
variance of the upstream component is invariant to changes in the covariance (Fig-
ure 2.7). In addition, the presence of a third unmeasured quantity can be revealed
by deviations from the ideal two node behavior (Figure 2.8,2.9). These proper-
ties are advantageous for studying the structure of signaling systems, indeed these
functional relationships are useful for inference tasks.
This analysis also provides information of the signaling networks parameteriza-
tion. Stimulating MAPK with PMA activates a cascade of biochemical reactions
that ultimately lead to the phosphorylation of MEK and ERK (Figure 2.3). Yet,
while the biology suggests that the cascade model should be superior, our data are
well approximated by the isolated two node system. Figure 2.10 demonstrates the
sensitivity of the functional relationships between covariance elements to changes
in the parameters of the cascade network. Interestingly, the biology of MAPK sig-
naling has selected for a parameterization that eliminates loops in the covariance
and variance plane. This suggests, that these systems make concerted efforts to
appear as an isolated two-node system [83]. It is intriguing that cells can tune their
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biochemical parameters to control for transmitted fluctuations instead of relying
upon negative feedback regulation alone.
Our results have shown that the combination of a simple single cell assay and
analysis of covariance elements provides insights to the structure of biochemical
networks. The functional relationships between covariance elements provide in-
sights to the direction of biochemical reactions, identify the existence of unmea-
sured components, and reveal novel network parameterization.
4.2 Variable responses of individual cells to chemical inhi-
bition
In this study we use a combined theoretical and experimental approach to extend
the mechanistic understanding of chemical inhibitors to living cells. We use single
cell phospho-profiling and Cell to Cell Variability Analysis (CCVA) [22] to per-
form detailed biochemical characterization of small molecule chemical inhibitors -
to date such detail has been limited to in vitro enzymatic assays. We also uncov-
ered a generalizable mechanism in which targeted enzyme inhibition manifests to
unique patterns of inhibition, digital vs. analog. Lastly, we probed the biologi-
cal significance of these results from short-timescale signaling behavior to unique
modes of inhibition of cellular proliferation.
Using single cell phospho-profiling and CCVA we were able to perform detailed
and mechanistic characterization of cellular responses to targeted inhibition in pri-
mary cells. Specifically, we showed how to utilize CCVA to mechanistically char-
acterize the biochemical interaction between the enzyme target and the inhibitor.
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We found that AZD1480 is a potent noncompetitive inhibitor JAK-STAT signaling
in IL-2 stimulated primary T lymphocytes (Figure 3.8). Remarkably, our measure-
ments highlight the promiscuity of AZD1480 when administered to primary cells
- IL2 receptor associates with JAK1 and JAK3 and not the ‘specific’ enzyme tar-
get of the drug, JAK2 [55]. In addition, we demonstrated how the organization
of reactions in biochemical networks determines the cellular response, analog or
digital, to inhibition (Figures 3.10,3.12). Although, Albeck et al also found that
inhibition of different enzymes manifest to digital or analog signaling responses
[3], we uniquely show how these disparate responses to inhibition are attributable
to the context of the targeted enzyme. Indeed, the dynamic properties associated
with the targeted enzyme’s location in the larger biochemical network determines
the networks response to inhibition (Figure 3.12). Furthermore, we showed how
our short timescale signaling behavior translates to novel long timescale prolifer-
ative response to inhibition (Figure 3.14). As a result, our methodology extends
in vitro characterization of inhibitor specificity and mechanism to primary single
cells and provides insights to nonlinear signaling responses from the biochemical
network structure.
Building upon our initial findings, we extended our mechanistic models and
used CCVA to demonstrate how cells utilize the endogenous variability of protein
abundance to generate disparate responses to singular perturbations. In context
to inhibition, we found that variation in enzyme substrate (STAT5) abundance
established diverse signaling amplitudes and varied the sensitivity of single cells
to inhibition (Figure 3.1,3.8). We then extended our mechanistic model of SRC
inhibition and found that the variability of SRC expression operates on cells as a
bifurcation parameter. As a result, cells that had elevated abundance of SRC are
more tolerant to inhibition (Figure 3.13). The extent in which these mechanisms of
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diversity provide resilience of populations to inhibition at longer timescales remains
an open question. However, the numerous examples of biological systems that
utilize protein abundance to generate phenotypic variability [28, 79, 76, 17, 41],
and the abundance of single cell observations showing heterogeneous responses of
cells to inhibition [75, 12, 14] suggest our findings are of practical importance.
By using our combined approach of CCVA and development of mechanistic
models to characterize drugs we were able to attribute single cell observations to
fundamental chemical and biological processes. We hope that this methodology
facilitates the extension of in vitro kinase assays to cellular systems and motivates a
transition from phenomenological characterization of single cell responses to drugs
into mechanistic understanding.
4.3 Future work
The goal of this work was to understand the properties of biological fluctuations in
the abundance of molecules and the variable responses of individual cells to chem-
ical inhibition. We have provided tools and methodologies to study single cell
processes, however our analysis has been constrained to snapshots of the under-
lying phenomena. These studies would be enhanced by using single cell temporal
measurements of the respective processes.
Temporal measurements of pMEK and ppERK activity would allow us to better
define the properties of the network. Currently, our fluctuation analysis assumes
that the fluctuations in molecular abundance are manifestations of stochasticity
in the chemical reactions and parameters, yet we do not have proof of this mecha-
nism. To prove such a mechanism we need to assess three components that are in
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Equation 2.28: the magnitude of the correlations in the abundance of molecules,
the timescale of the observed correlations, and lastly the presumed ergodicity of
the system. Our single cell assays of signal transduction preclude the repeated ob-
servations of biochemical signaling in individual cells. While this does not prevent
estimation to the magnitude of biochemical fluctuations, it forbids the proper as-
sessment of the correlation timescale - by computing the autocorrelation and cross-
correlation functions - and proof of ergodicity. As a result, temporal measurements
of signaling in single cells is the most pressing next step in this research.
Furthermore, repeated cell measurements would facilitate our mechanistic un-
derstanding of chemical inhibitors. Our current model of signaling suggests that
the endogenous variability of protein tunes the responsiveness of cells to SRC in-
hibition. We were not able to extend these findings to the proliferative timescale,
because we could not track individual cells over time. Concomitant monitoring of
single cell ppERK signaling and CD8 in time would provide the necessary mea-
surements to demonstrate our prediction.
Pioneering work by Albeck et al. [3] used FRET reporters of ERK signaling
to monitor signaling over time [47, 5]. Strikingly, they observed that this pathway
produced stochastic pulses that changed frequency with dose of Epidermal Growth
Factor (EGF), a potent activator of MAPK signaling in the human mammary cell
line, MCF10A. The most striking and under-appreciated finding was that the pat-
terns of activity of each cell were unique, and that they were able to switch in
time. For example, some cells would be activated for several hours, then sponta-
neously switch to limit cycle oscillations, and back. The underlying mechanisms
of the observed diversity were not investigated by the authors. In context to our
assumed parameter fluctuations and the nonlinearities in the MAPK pathway [67],
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this system can easily sample from the observed dynamics phenotypes. It would
be fascinating if biological system purposefully used fluctuations in parameters
(e.g. protein concentration per cell) to sample dynamic signaling phenotypes as a
mechanism to maintain physiological viability.
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